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SUMMARY
An outline is given of the present state of knowledge
regarding the pathogenesis of sorapie agents in mioe. Emphasis is
laid on the unoonventional nature of the disease and its causal
agent.
A methods section describes the relevant aspeots of the
special methodology which has been developed in the research
institutes where this thesis was written.
An investigation of the inoubation periods of three
different strains of sorapie agent injected at a range of ages from
birth to weaning in three strains of inbred mice shows that the
undeveloped state of these hosts at birth causes a considerable
modification of pathogenesis: in particular, many newborn mice do
not develop sorapie after a dose which would always kill weanling3.
Reasons are given for suspecting that the relevant undeveloped organ
system is the lymphoretioular system, and that some form of sorapie
•inaotivation' must also be involved.
Attempts to throw light on agent pathogenesis by looking
for pharmacological treatments whioh will change inoubation periods,
produced numerous negative results (outlined) and some positive ones
(described in full). Using the i.p. route of agent injection and
drug treatment in the weeks immediately before and after infection,
signifioantly changed inoubation periods were obtained with prednisone
acetate, arachis oil, prednisone acetate + cyclophosphamide, and
prednisone acetate + peritoneal-oell provocation with thioglyoollate
ii
medium. Preliminary positive results using neonatal treatment with
6-hydroxydopamine and adult treatment with phytohaemagglutinin are
also desoribed. Evidence is reported for a prolonging of inoubation
period of i.o. injected agent by subsequent actinongrcin D injections.
Experiments are desoribed in which the peripheral
pathogenesis of ME7 sorapie appears to be greatly modified both in
terms of incubation period and pattern of lesion distribution in the
brain by donor-tissue components. Observations on the histological
differences are reported and a number of experiments desoribed which
suggest that agent pathogenesis may require specific reactions of an
immunological type on the part of the host to donor-specified antigens
in the inoculum.
It is shown in a large range of agent/host strain
combinations that there are early ohanges in drinking (and in some
cases feeding) habits of mice infected with sorapie. Reasons are
given for believing that these are due to an upset of normal brain
funotion by the agent the physiological basis of whioh is close to
the primary lesion due to scrapie, i.e. some derangement of the funotion
of the sine gene or its immediate product (SECTION 2). The
possibility that this is an upset in catecholamine function is
discussed.
A number of experiments and observations ancillary to the
main seotions are collected in five appendices.
Full discussions are given at the end of each SECTION, while
in the Final Discussion an attempt is made to bring all the above
observations together and to point the way to further researoh.
Several alternative models of sorapie pathogenesis in peripheral organs
are briefly reviewed.
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the period (in days) between injection with
sorapie and the date of confirmed positive
olinical sorapie (carefully defined in
SECTION 2). This gives end-points which usually
have a normal distribution about a mean date
shortly before death.
incubation period after i.p. route (days)
incubation period after i.e. route (days;
inoubation period in VM mice (p7p7)
incubation period in C57 mioe (s7a7)
a gene of unknown function in the normal mouse
which governs the inoubation period of all scrapie
agents so far investigated, (sine - scrapie
inoubation). Two alleles are known: s7 and p7.
a quantitative description of the density and
distribution of vaouolar lesions in the
grey-matter of the mouse brain resulting from
sorapie infeotlon.
iv
oedema a white-matter vaouolation characteristic of











INTRODUCTION SO THE PATHOGENESIS OF SCRAPIE IE MICE
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INTRODUCTION TO THE PATHOGENESIS OF SCRAPIE IN MICE
The pathogenesis of scrapie in mice is still very little
understood. During the last decade, since the first successful
transmission of the disease into this unnatural host, much of the early
experimental work was conoerned with establishing that murine scrapie
was the same as the natural disease in sheep - that it still showed a
similar range of unusual biological and physico-chemical properties.
The main obstacle to rapid advance has been that the only way of
detecting the agent is by injection of living hosts and waiting several
months for the disease to develop, while to assay it involves the even
longer process of titration in living animals. Since the incubation
periods in mice, even with the maximum possible doses are anything from
four months to a year and a half (according to the combination of agent
strain and host genotype used), and with the LD^-q end-point doses
taking years rather than months to produce clinical signs and death,
progress has necessarily been slow.
It is also possible that a full understanding of this disease
and the nature of the causal agent will have to wait for extensions of
our knowledge in a number of specialised fields, notably, neuro¬
physiology, the biology of the lymphoreticular system, virology and
perhaps molecular biology, so that our relative ignorance is perhaps
not surprising. Despite these limitations, the literature on scrapie
and other slow-viral encephalopathies is extensive and many reviews
have been attempted. The most recent, by Kimberlin (1973) is the most
adequate so far, being written by a worker with a wide knowledge of
scrapie research.
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Scrapie is a natural disease of sheep, and occasionally of
goats. Experimentally, however, it has been transmitted to several
species of laboratory mammals, mostly rodents. The use of mice as
hosts has made possible a much more economical experimental procedure
than in sheep or goats, and strict experimental control is only
possible by using inbred strains. It is not generally realised,
however, that there is little difference in the absolute length of
incubation periods in sheep and mice when the same strain of agent is
used.
Scrapie is the best known and understood member of a group
of mammalian central nervous system diseases, all of which have a
similar histopathology and clinical pattern of disease. Various
provisional names have been proposed for them, the least objectionable
of which is probably 'the slow-viral encephalopathies', although even
this assumes a viral origin, which maqy workers consider unlikely.
Another animal disease in the group is transmissible mink
encephalopathy (THE) (Marsh et. al., 1969). Two relatively rare human
CNS diseases are also included: the well-known affliction of certain
tribes in New Guinea called 'kuru' (Hadlow, 1959; Gajdusek et. al.,
1966, 1967; Gibbs et. al., 1969) and Creutsfeldt-vTakob disease
(Gibbs et. al., 1968). These four encephalopathies are included at a
higher level of classification in Sigurdsson's 'slow-viral diseases'
(Sigurdsson, 1954) which also contains some instances of true viral
infections. In the opinion of some there is sufficient evidence also
to add multiple sclerosis to the group (Field, 1970), although there is
as yet only indirect and inconclusive microbiological and epidemiological
evidence for an infective aetiology, and its pathology is very different
from that of the four slow-viral encephalopathies mentioned above.
Characteristic features of the slow-viral encephalopathies,
including scrapie are:
causal agents of an unconventional kind having a combination
of unusual properties which do not occur together in classical viruses;
long incubation periods lasting from 4 months to 7 years or
more, during which the agent appears to replicate slowly but
continuously, especially in the lymphoreticular tissues, and eventually
in the brain and spinal cord;
- throughout most of this replicative phase there are no
obvious signs or symptoms of illness;
the clinical phase, which occupies only a small fraction of
the incubation period, is characterised mainly by various motor upsets,
and is probably invariably fatal (it is so, at present, by definition);
- the microscopic lesions are of a degenerative but non¬
inflammatory nature and are confined to the central nervous system
(CNS), although it is possible that all those so far reported are of a
secondary nature and have no direct relation to the cause of death.
Experimental scrapie in mice appears to be essentially the
same as the natural disease in sheep, and there are no serious reasons
for supposing that it is not an adequate model with which to work.
There are some differences, however, the most oonspicuous being that
'scraping' due to a persistent pruritis is rare in the murine disease
(it is not universal in sheep), although it does oocur in certain
agent/mouse strain combinations (Pattison & Jones, 1968;
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Dickinson, pers. comm.). Care is, of course, needed to distinguish
this from skin damage due to parasites or fighting. Probably a much
more important and interesting difference is the fact that maternal
transmission and lateral oontagion are found in the natural sheep
disease (Dickinson, Young, Stamp & Renwick, 1964, 1965; Dickinson,
Young & Renwick, 1966; Dickinson, Maoksy & Zlotnik, 1964; Dickinson,
1967) but neither seem to occur in mice (Clarke & Haig, 1971)•
Reported instanoes of lateral contagion in mice are likely to be due
to oral infection either from oozed inocula or from cannibalism
(Dickinson, et. al., 1964; Pattison, 1964). Excretion of infective
agent in the urine or faeces during the oourse of the disease has never
been found in sheep or mice.
Work in the laboratories where this thesis was written has
demonstrated the existence of many strains of scrapie agent each with
its own interactions with different genotypes of mouse ho3t.
Consciousness of our incomplete knowledge of this range of variation
makes it difficult to be confident about generalisations. With this
qualification in mind, the following is an outline of what 3eems to be
the usual course of pathogenesis in those agent/host strain combinations
showing the shorter type of incubation period. The reasons for this
restriction will become apparent in SECTION 2.
Y«'hen scrapie inocula are injected by the intracerebral (i.e.)
route (as is most frequently done since this gives the shortest
incubation periods) most of the agent probably passes immediately into
the circulation and within a few days begins to replicate in the organs
of the lymphoreticular system. However, there is much evidence to
suggest that death after an i.e. injection is caused by the agent which
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has remained in the brain and replicated there and not by the
considerable amounts of peripherally replicated agent. The main kinds
of evidence are:
the much shorter incubation periods after, i.e. than after
peripheral injections (e.g. intravenous, i.v. and intra¬
peritoneal, i.p.) and in particular, the failure of i.o.
injection of saline to radioally shorten the incubation period
of i.v. scrapie;
- the brain lesion distribution resulting from intracerebral
injection is different from that for peripheral injection and
this is not merely due to the cerebral trauma of injection
(Eraser, 1971) (lesion profiles - see SECTION 2);
splenectomy, whether before or after injection, prolongs the
incubation period of i.p. but not i.e. injected scrapie;
- hereditarily spleenless mice (Dh/+) show identical i.e.
incubation periods to their (+/+) litter mates with spleens,
but longer i.p. inoubation periods;
estimates of titre by assay in living hosts show at least a
ten-fold higher value by the i.o. than by an i.p. route
(Dickinson, pers. comm.; Carp, pers. comm.);
- standard scrapie injections (see SECTION 2) given by the i.e.
route to neonatal mice show essentially the same incubation
period as weanlings, while the same dose given to neonates by
the i.p. route often produces no disease at all (SECTION 3).
On the other hand, treatments of the host which have affected
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the pathogenesis of peripherally injected scrapie do not affect
the incubation period of i.e. injected agent (SECTION 4).
A rise in titre in the brain after an i.e. injection can be
deteoted about 2 months later. The timing appears to be largely under
the control of an autosomal gene called sine (an acronym for scrapie
incubation. Dickinson et. al., 1968 and SECTION 2). Also at this time,
numerous changes occur in brain physiology (3ee below) although
behavioural changes are not apparent, even to experienced observers
without the use of sensitive tests (SECTION 6). Eventually, four or
more months after the i.e. injection, clinical signs begin, and within
a few weeks the mice are dead.
When, however, the agent is administered by a peripheral route
(most oommonly intraperitoneal, i.p.) then several extra steps in
pathogenesis seem to occur, resulting in both longer incubation periods
and lower estimates of titre. Although unpopular with scrapie workers
on account of the even longer incubation periods, this route has
compensatory advantages of its own and is the one most used in this
thesis. It is, for instance, arguably a more •natural' route than
the i.e. one, and there are good reasons for concluding that an i.e.
injection bypasses some normal early steps in pathogenesis whereby the
host is able to exercise a limited control over the fate of peripherally
administered agent. There is the possibility that an understanding
of these early steps may hold out hope for discovering methods for
controlling the disease. Further, since the replication of the
agent in extraneural organs is also under the close control of the
sine gene (Dickinson & Fraser, 1969; Diokinson, pers. comm.) the
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association is likely to be more accessible to investigation by various
types of biological or biochemical interference in the periphery than
in the CNS, since the blood-brain-barrier and various other difficulties
render the brain relatively inaccessible to biochemical and surgical
manipulations.
After a peripheral injeotion (a3 after an i.e. one) there is
a rapid inorease in titre of the agent in the spleen (Sklund, et. al.f
1967; Dickinson & Fraser, 1969; Hunter, et. al., 1972). It is
probable that this is mainly due to replication there, although it is
reasonable to assume that at least some of the inorease is the result
of accumulation. By 2 months after an i.e. route, and a few days
later after i.p. injections the spleen titre seems to plateau
(suggesting either site-saturation or a steady turnover of agent either
by inactivation or export) (Sklund, et. al., 1965; Diokinson, et. al.,
1969). 12-16 weeks after peripheral injections the titre begins to
rise in the brain. The mode of transport from the periphery is
unknown and there is no satisfactory evidence that it is present in
circulating blood. Once in the brain, the peripherally injected
agent appears to replicate in the same manner and at the same rate as
a centrally injected agent, although there are often considerable
differences in lesion profile from the same agent after injection by
the two routes (Fraser, 1971 and pers. comm.; Outram, Fraser & Wilson,
1973; and SECTIONS 2 & 5).
It should be emphasised that the above outline is a
generalisation from many published and unpublished experiments in
these and other laboratories, using various (and often poorly defined)
strains of agent, host genotype and routes of injection. There are
agent/host strain combinations that depart radically from this out¬
line (at least in terms of timing) and the exact range of variation
is unknown. As a result there is a strong inclination to U3e
operational descriptions and so avoid premature generalisations and
this preference results in the frequent use in this thesis of
expressions like 'agent/host strain combinations' and 'different
combinations'.
The details of the clinical signs also vary considerably
with agent and mouse strain; they include: inco-ordination of
gait, circling locomotion, swollen bladder and incontinence, priapism,
phases of excitibility or somnolence, pruritis, and subtle upsets of
behaviour such as ohanges in drinking and feeding habits (SECTION 6)
and reactions in emergence and open field testing.
The known histological lesions are confined to the CNS,
but only very general and equivocal correlations have been made
between their details and the above range of functional disturbances.
The most obvious brain lesions, using simple staining techniques, are
the vacuoles in the neurones and the neuropil of the grey-matter, and
in some agent/host strain combinations a vacuolation of the white
matter (which will be referred to subsequently as 'oedema' to
distinguish it from grey-matter vacuolation). These appear soon
after the first clearly detectable rise in brain titre, and increase
progressively in intensity, apparently in step with this rise in
titre (Praser & Dickinson, 1968; Pattison & Smith, 1963). Other
staining techniques show an early hypertrophy of the astroglia with
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a slight increase in numbers (Pattison, 1965; Field, 1970; Giorgi,
et. al., 1971), fibre degeneration (Fraser, 1969), deposition of
neutral fat (Mackenzie & Wilson, 1966) and in some combinations the
formation of anyloid plaques (Fraser & Bruce, 1973). Several
biochemioal changes have also been described, including changes in
the metabolism of DNA, histones, ATP, polyamines, glycosidases, and
fucose. These are reviewed by Kimberlin (1973) but their exact
significance is still uncertain and their status as primaiy or
secondary effects in doubt (Little & Adams, 1971)•
The pattern of the distribution in the brain of the vaouolar
lesions in the grey-matter of mice has been subjected to much analysis
in these laboratories (Fraser & Dickinson, 1973 and. SECTION 2). There
is considerable variation between different agent/host strain
combinations coupled with a remarkably high degree of consistency
within them.
Despite the discovery of all these sorapie-assoolated
phenomena and of the detailed analysis of some of them, the oause of
death is unknown and there are as yet no methods of prophylaxis or
cure once infection has become established (but see SECTION k).
The necessity for special approaches in scrapie research
Much of the work so far on scrapie has drawn attention to
the unconventional nature of the disease and its causal agent, which
has tended therefore to be merely negatively characterised. This
state of affairs provides a great challenge and requires a readiness
to work in ways that are untrarameled by the usual notions of how to
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investigate viral diseases. Scrapie has proved refractory to a wide
range of conventional approaches, which, although they had to be tried
in the normal course of events, have had to be abandoned or drastically
modified. For instance, while it is usual to bemoan the long
incubation periods and to endeavour therefore by all means to reduce
them, this is compensated by the fact that operationally exact
experimental replicates give extraordinarily similar results despite
the long times involved. This fact is itself of great biological
interest, demanding an explanation, but it also permits an economic
style of experimentation using numerous small-scale pilot experiments
for the initial exploration of interesting observations.
The necessity for a special approach to this disease is best
demonstrated by summarising the outstanding anomalous features as
compared with conventional viruses.
1. Very long incubation periods but of very consistent length and
showing a standard error of the mean of only a day or two (especially
after intracerebral injections). The length of the incubation period
also increases in a highly predictable way as the dose is decreased.
The proportionate increase of incubation period for the i.p. route,
compared with the i.e. route, is relatively constant for each agent/host
strain combination (Dickinson & Outram, 1973; Dickinson, pers. comm.).
2. No conventional immunological responses by infected hosts have
been demonstrated (Chandler, 1959; Gardiner, 1966; Haig & Clarke,
19^5; Clarke & Haig, 1966; Gibbs, Gadjusek & Morris, 19^5;
Clarke, 1968; Katz & Koprowski, 1968) nor is there any sign of a
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general depression of immune responsiveness as is known to occur with
some viruses (Clarke, 1968; Gardiner & Maruoci, 1969). Because of
the association of the agent with the lymphoreticular system, numerous
experiments have been published attempting to change incubation periods
by using immunosuppressive techniques. For instance, treatment with
cyclophosphamide (Worthington & Clarke, 1971) or adult thymeotony
followed by irradiation and reconstitution with foetal liver (McFarlin,
et. al., 1971). Other investigators have tried neonatal thymectomy
(Gibbons & Hunter, 1967) and antalymphocytic serum (Hirsch, 1970) but
unfortunately chose to inject scrapie by the i.e. route. All such
treatments have failed to influence the course of the disease. This
lack of immunological responsiveness to scrapie is also serious from an
experimental point of view because it excludes the use of techniques
like serological identification, visualisation by immunofluorescence,
and estimation by immunoassay. Recently, Field et. al. (1972) have
reported some subtle changes in lymphocytes taken from scrapie animals
which may have an immunological basis, but it is too soon to assess the
significance of these findings.
3. There has been no suocess with attempts to use tissue-oultures as
assay systems, or for rapidly preparing high titres of relatively pure
agent. A slow rate of replication in cultures of cells of unknown
type derived from infected mouse brains has been demonstrated
(Clarke & Haig, 1970) but it has not been possible to show infection
of normal tissue cultures with agent. The infeoted cultures of
Clarke and Haig have not been usable for biochemical investigations
because of the lack of axy acceptable kind of control cells, nor do
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they release active agent into the supemate.
4. Progress in understanding the agent in conventional terms has been
hampered by an inability to purify it or even to produce any
concentration of activity higher than that found in crude brain
homogenates. There is evidence, at least in the case of some agents,
that infectivity is most strongly associated with extracted
plasma-membrane fragments. This does not necessarily tell us any¬
thing about the in vivo site of activity, and interpretation of such
findings is difficult. This has not deterred some from attempting to
construct models of the scrapie agent in terms of modified
host-membranes (Gibbons & Hunter, 1967; Adams, 1970). These are
almost certainly premature and even now cannot account for maiy
important findings, notably those involving the interactions of agents
with the sine gene (see below and SECTION 2).
5. The agent has never been identified with the electron microscope,
although numerous peouliar features of infected cells have been
reported (Chandler, 1967; Field & Narang, 1972). It is likely that
this is because the agent is very small, associated with host tissue,
perhaps only present as a few units per cell, and may be visually
indistinguishable from maiy normal constituents of cells. Estimates
of agent particle size using filtration and irradiation techniques
(both subject to numerous difficulties in interpretation especially
when orude tissue suspensions have to be used) have given measurements
of 20-50 nm. in the smallest physical dimension (Kimberlin et. al., 1971)
and an inactivation target size of 7 nm. (Alper, et. al., 1966).
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Estimates of the average numbers of infectious units in tissues are in
the order of 1 unit per brain cell (in terminally affected animals) and
1/50 for the spleen. It is not known if this represents a high
infection of a few cells or a low infection of many. It is not
difficult to see how these kinds of numbers and dimensions could make
difficulties for electronmicrosoopists.
6. There are practical problems in estimating the titre of scrapie
agents in infected tissues. The only fully satisfactory method at
present is by titration in whole hosts to find the dose. It
should be emphasised, however, that this is only an operational
definition of titre and the estimates are known to vary according to
the precise test conditions including the host genotype (Dickinson &
Meikle, 1971). While it is true that when a particular agent/host-strain
combination is well understood, titre can be estimated from the
incubation period of a single dilution, it is necessary to be vezy care¬
ful since a change in incubation period can occur from other causes
even when the titre remains the same.
7. The existence of numerous strains of agent with a wide variety of
biological properties raises other potential problems. For mapy types
of experiment it is important to be certain that one is using only a
single agent and not a mixture of strains. The evidence is that
affected sheep and goats are often infected with more than one strain
of agent: this conclusion is based upon much work in these laboratories
involving transmission to mice and the analysis of subsequent passages
in mice of different genotypes (Fraser & Dickinson, 1973). Since
these agents can differ considerably in terms of their incubation
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periods, pathology, and resistance to physical and chemical treatments,
the use of mixtures (such as the Chandler 'agent') in experiments
could lead to serious errors of interpretation if the presence of
more than one agent was not recognised. The above mentioned scrapie
material has been very widely used in this country and abroad, and this
is one of a number of reasons for having serious misgivings about some
of the generalisations regarding the properties of "scrapie" that
have been based upon it.
8. The genotype of the host can also have a marked effect upon the
incubation period and patterns of lesion distribution in the brain
caused by a particular strain of agent. One gene is known in mice
that can more than double or halve the incubation periods of specified
agents according to the allele or combination of alleles present in the
host (see SECTION 2). Clearly, if one is using experimental mice that
are segregating for this gene it will provide a source of great
variation in incubation period within experiments and a cause of
uncontrolled variations between replicates - unless one uses
prohibitively large numbers of animals.
9. Most scrapie agents show a remarkable degree of resistance to
inactivation by standard sterilizing procedures, including conventional
autoclaving, irradiation treatments, boiling, and immersion in formalin,
although variation between strains is still largely unexplored and seems
to be greater than is generally appreciated. This puts a question
mark against some attempts to speculate about the nature of 'the scrapie
agent' on the basis of this resistance. It is also important to
recognise that without stringent precautions, these properties
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constitute a danger, perhaps to personnel, but certainly to experi¬
mental results, because of the greatly increased possibility of
contamination in general, and cross-contamination (of strains) in
particular.
10, Finally, and largely in consequence of the previous nine features
of sorapie, there is as yet no widely accepted model for the scrapie
phenomenon, nor an agreed methodology. Instead one finds groups of
workers in separate centres pursuing their own lines of research in
relative isolation from each other and with only enough common ground
for misunderstanding. This is a situation common in new scientific
fields, which leads inevitably to difficulties in understanding,
assessing and using the results of others - and sometimes to controversy.
Tactical considerations in consequence of the foregoing
The peculiar nature of scrapie as thus outlined obviously
requires special tactics for its investigation. This thesis work is
modelled on the methods which have been developed by A.G-. Dickinson
and his colleagues in Edinburgh (see SECTION 2). The chief tactical
procedures of this method are:
1. The avoidance of premature specialisation by advancing on a broad
biological front, endeavouring always to identify primaiy effects of the
agent which may eventually merit more specialised attention.
2. A concentration on the study of biological variation since this
will help to identify primary effects which will tend to have a wide
generality from secondary ones which may not. This approach has
already identified a gene (sine) whose two known alleles (s7 and p7)
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oontrol the onset of replication of all agents so far tested and in
such a manner as to suggest a very close relation between gene function
and agent replication (Dickinson & Meikle, 1971).
3. To be constantly on the look-out for new scrapie-associated
phenomena in experiments designed for other purposes. This requires
a close involvement of the research staff with the experimental animals
throughout the incubation period,
4. To open up investigations of interesting new findings with a
range of small-scale pilot experiments that rely to some extent upon
previous experience with the particular agent/host strain combination
to provide controls. Larger experiments with more and tighter controls
are not designed until these pilots have shown the scope of the
phenomenon. Investigation by titration, which is often necessary for
the purposes of clarification is not usually begun until several years
after the initial observation.
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SECTION 2
METHODS; AN OUTLINE OP THE RELEVANT METHODOLOGY OP THE
JOINT SCRAPIE UNIT OP THE ANIMAL BREEDING RESEARCH ORGANISATION
AND THE MOREDUN RESEARCH INSTITUTE, EDINBURGH.
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2.1 GENERAL INTRODUCTION TO THE SCRAPIE METHODOLOGY DEVISED IN THE
A.B.R.O. - MDREDUN INSTITUTS SCRAPIE UNIT.
On account of the special features which are associated with
sorapie research as outlined in SECTION 1, it has been necessary to
devise appropriate methods for investigating this disease. A strategy
has been developed by Dr. A.G. Dickinson and his colleagues in the above
unit whioh uses oertain conventional virologioal methods supplemented
by several original procedures. Since this composite approach forms
the foundation of the methods used in this thesis, it is necessary to
give some account of it by way of introduction and to provide an
overall 'Materials and Methods' SECTION to obviate the need for
repetition later.
The most characteristic feature of this approach to sorapie
research is an emphasis on the need to analyse the full extent of
biological variation in the disease. In this way it avoids the dangers
of the more obvious procedure which is to use only the quiokeat, most
convenient host/agent combination in attempting to investigate either
the agent itself by direct physico-chemical techniques or in the study
of pathogenesis. The point is that there are so znary seoondary
features of the disease, raary of which are only associated with certain
specific agent/host strain combinations, that it is extremely easy to
waste resouroes pursuing such features without any hope of revealing
new fundamental knowledge about the disease and its causal agent.
Without discounting the importance and possibility of occasional lucky
breaks, the chances are that the best way to identify fundamental
features is by a broad biological approach in which the generality of
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specifio observations can be checked. Only when such primary aspeots
have been identified with certainty will it be time for specialist
investigations. This procedure is analogous to that of genetios
before the eluoidation of the molecular nature of the gene and its
mode of operation. Not only was this classical work extremely fruit¬
ful in making relevant discoveries, despite the ignorance about basic
mechanisms, it provided the foundation on which molecular biology was
eventually to be built. Moreover, even now the classical procedures
are by no means redundant since a large amount of clarification remains
to be done and molecular biology has not supplied all the answers
which some expected of it. It is argued, similarly, that in scrapie
research at the present time, the most appropriate methodology is a
patient analysis of its general biology, in particular of the kinds of
variation that are displayed and their interrelations, without being
greatly worried about the lack of a model of the central prooesses.
Attempts to construct suoh models are hardly likely to be correct at
this time since they can only be based upon fragmentary knowledge
(what chance would even the most knowledgeable biologist have had of
providing an adequate model of the gene in say 1930?).
The outstanding achievements of the general biological approaoh
to scrapie in mice used by this unit in the past decade have been,
firstly, to develop several refined parameters of measurement based
on two types of observation, namely, the incubation period and the
lesion profile in the brain, and secondly, to show that a number of
natural and experimental variables have a profound effect upon the
pathogenesis of sorapie in mice as shown by changes in these
parameters. The chief sources of scrapie variation that have so far
been identified are:
the strain of the agent, of which 8 different ones are known
in some detail and about 10 others more tentatively (some of the best
characterised strains have been re-isolated several times; Dickinson
& Meikle, 1971; Fraser & Dickinson, 1973);
some form of interference between different strains of agent
in mixed infections produoing prolonged incubation periods end inter¬
preted as competition for replication sites (Dickinson, Fraser, Meikle
& Outram, 1972);
the genotype of the host, especially with respect to the gene
sine of which two alleles s7 and p7 exercise a very profound influence
upon the incubation period of all strains of agent so far tested
(Dickinson & Meikle, 1971; Dickinson, pers. comm.);
- operational procedures such as dose of the agent, route of
injection, the infectious tissue used, and the strain of the donor
(Dickinson & Meikle, 19^9; Fraser & Dickinson, 1973; Dickinson &
Outram, 1973; Outram, Fraser & Wilson, 1973);
- integrity and maturity of the lymphoreticular system where
peripheral routes of injection are involved (Fraser & Dickinson, 1970;
Dickinson & Fraser, 1972; Outram, Dickinson & Fraser, 1973).
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2.2 OUTLINE OF METHODS
The main procedures that have achieved these results are:
1. The use of several standard agents which have been obtained, at
least in partially purified form by multiple passage in specific
strains of mice, with cloning techniques in some cases.
2. The use as hosts of numerous, fully inbred strains of mice and
genetically controlled crosses, housed in a uniform environment.
3. The use of very rigorous aseptic procedures for the removal and
storage of tissues and the preparation and injection of infectious
inocula which are designed to prevent contamination and
oross-oontamination. These procedures, in conjunction with those
described in 1 and 2 above, give results which are so consistent
that much smaller numbers of animals can be used than would other¬
wise be necessaiy to obtain accurate results. The degree of
control whioh has now been achieved permits valid comparisons to
be made with a corpus of reference standards whioh minimise the
number of types of contemporary controls needed in pilot
experiments.
4. The scoring of incubation periods and the topographical
distribution and density of brain lesions is done using coded
mouse- and tissue-samples, in which the scorer is unaware of the
specific nature of the experiment and of apy detailed expectations
regarding the results. Also, appropriate degrees of randomisation
of individual mouse treatments within oages are used, so that
group-behavioural interactions among cage-mates are not
confounded with treatment groups.
- 23 -
5. The very full recording of all biological and clinical details of
every individual mouse from birth to post-mortem analysis, including
those of an incidental nature whose significance may only become
apparent much later.
2.3 MATERIALS MP METHODS (GIVING- DETAILS RELEVANT TO THIS THESIS)
The following paragraphs will expand the above points where
they are especially relevant as a background to SECTIONS 3-6.
2.3a Inbred Mouse Strains. More than 20 inbred mouse strains
have been used in these laboratories. Table 2.1 shows some of the
incubation period characteristics of the agents and mouse strains which
have been used in this thesis. All the incubation periods quoted are
for an intracerebral (i.e.) injection of lightly oentrifuged
(500g, 10 mins.) \% saline homogenate of terminally affected mouse
brain.
These data illustrate the wide variety of lengths of incubation
that are obtained with different agent/host strain combinations, and
the remarkably 3mall variation about the group mean whioh obtains even
with the longest of them. Of particular importance are the effects
of the various sine genotypes. The effects of this gene are almost
without precedent in genetics (although systems with some similarities
are known in yeast, Zimmermann & Gundelach, 1969) and the only simple
method of understanding the results which its two alleles produce,
is in terms of a very close relation between one of the immediate
produots of the gene (or the gene itself) and the requirements for
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homozygotes p7p7 and s7s7 constitute the basis for the grouping of
scrapie agents into two classes. The *ME7 group' of agents shows the
shorter incubation period in C57 mice (s7s7; s7 = short incubation
with ME7) while they have a muoh longer incubation period in VM mice
(p7p7; p7 = prolonged incubation with ME7). On the other hand, the
'22A agent group' shows a short incubation period in VM mioe and a
prolonged incubation period in C57 mice. Other members of this 22A
group are known but were not used in this thesis.
The incubation period in the F (s7p7), depending on the
particular agent, is either intermediate between the two homozygotes,
or as long as the longer one, or even significantly longer than either
homozygote (termed overdominance). (See Table 2.1 and Dickinson &
Meikle, 1971). This interaction between scrapie agents and some
immediate product of the sine gene in order for the agent to replioate,
is the most primary effect yet discovered in scrapie pathogenesis, and
it would not have been detected without the discovery of variation at
the sine locus. However, the role of this gene in the uninfected
mouse is not yet known and there are no valid grounds for speculating
about its normal function.
2.3b Scrapie Agents. At least 18 different scrapie agents
have now been isolated in this Unit, but they vary in current passage
state and consequently in the reliability of detailed information
about their characteristics. The agents are distinguished by
operational parameters such as the lesion profile and their relative
incubation periods in different genotypes of mouse - although the
molecular bases of their differences are not yet known.
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All agents have a passage history that leads back eventually
to diseased sheep or goats, although the details are sometimes
oomplex, and in the case of 3 agents open to alternative inter-
pretations regarding the true source. Table 2.2 shows the origins
and passage histories of the agents used in this thesis. One of the
5 shown, MK7, is the most stable known and its properties are
unaffeoted whether it is passaged repeatedly in either C57 or VM mice.
It is not yet known whether this holds true for the other 4 agents.
2.3c Uniform Host Environment. The use of inbred mice
provides for the control of the internal environment of the host and
it is wise on general principles for quantitative measurement in
biological systems, to exercise as much control as possible over the
external environment of the host also. Accordingly the rooms, whioh
house about 8000 mice, are maintained by air-conditioning at a
temperature of 21° C and a R.H. of 45-55i^. Although indirect sun¬
light illuminates the rooms, seasonal variation is partially counter¬
acted by electric lighting for 12 hrs. every day throughout the year.
The animals are caged, up to six at a time, in polypropylene cages
with welded wire, stainless-steel lids, shaped to hold an overhead
supply of dry pelleted food (Spiller*s steam-heated diet) and a
rigid plastic drinking bottle with a glass drinking tube. Food and
water are supplied ad libitum. Once a week, immediately after
scoring of clinical signs, the mice are transferred to clean cages
containing sterile litter. Fresh drinking water is given at least
twice a week. All cages are checked daily. The normal procedure
and precautions for the maintenance of a SPF colony are observed, and
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Table 2.2 Sources of Scrapie Agents
Designation Source and history prior to passage to inbred mioe
ME7 2nd passage brain from random-bred Moredun-stock
mouse. Originated from the spleen of a Suffolk
sheep naturally affected with scrapie
(Zlotnik & Rennie, 1963).
79A * Brain pool from goat with •drowsy* form of
experimental scrapie (Pattison & Millson, 1961)
at the 8th goat passage; it is possible that
this agent does not originate from scrapie in
sheep (Dickinson, pers. comm.)
80A ^ Brain pool from goat with 'scratching* form of
experimental scrapie (Pattison & Millson, 1961)
at the 5th goat passage.
22C * Cheviot sheep brain pool at the 21st 3heep
passage of SSBP/1.
22A * Cheviot sheep brain pool at the 21st sheep
passage of SSBP/1.
* These agents stem from a common origin at the 16th sheep to
sheep passage of Cheviot sheep scrapie brain pool of the Moredun
Institute (SSBP/l). Prior to its isolation in goats, this was
further passaged twice in sheep at Compton (firstly in Cheviots, and
then in the Welsh Mountain breed). The isolation in mice of the
source which yielded 22A and 22C was passaged a further 5 times through
Cheviot sheep at the Moredun Institute.
80A and 22C are probably the same agent: they both stem from the
SSBP/1 pool and have similar properties even though their lineages
differ by 7 sheep and 5 goat passages.
22A is standardly passaged in VM mice (sine p7p7): the other agents
standardly in C57 mice (sine s7s7).
* 79A is probably the chief constituent agent of the widely used
"Chandler-strain" of scrapie.
access is strictly limited.
2.3d The Preparation of Inooula and Injection Procedures. The
mice are infected with scrapie by injection with inooula derived from
crude tissue homogenates in saline: these inocula are the supernatant
fluids of centrifuge! homogenates and are referred to as " supernates"
for brevity. The homogenates may be of sheep or goat brains or
spleens, but more usually they are from mouse tissues. Some sources
for this thesis were homogenised pools of several brains, while others
were single half-brains or spleens that had not been homogenised.
o
Tissues were stored at -30 C in labelled, screw-top glass bottles.
The reason why only half the brain is usually frozen is that it is
normal to send the other half for histological examination. The
infectivity of the frozen tissues survives unimpaired for mapy years
at least.
Supernates were prepared as follows. The tissue was thawed
and a portion removed and weighed using aseptic techniques. It was
homogenised in sterile isotonic saline (usually to give a or 10^
w/v homogenate) using a high-speed, teflon-in-glas3, shearing
homogeniser and giving about 20 strokes of the plunger. The homo¬
genate was then lightly oentrifuged at either 500g for 10 mins., or
2000g for 15 mins. These alternatives relate to previous standards
which had been used and were adopted in this work for confirmity.
Very occasionally an unspun homogenate was used as when it was required
merely to detect the presence of agent even at low titre. For the
convenience of small experiments using only a few animals, some aliqots
of supernates were frozen at -30° C. When required for use these
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were thawed, agitated in the syringe and injected as usual. A titre
check on one such 79A frozen supernate showed an estimated loss of
titre of 1 log units after 750 days of storage.
Injections were nearly always by the intraperitoneal (i.p.)
route although the i.e. and the oral routes were occasionally used.
All scrapie injections in this thesis used a volume of 0.02 ml.,
without anaesthetic and employing a 26 G disposable hypodermic needle
and syringe. The above details will be referred to in the thesis by
the expressions "standard supernate" and "standard frozen supernate".
The former expression means 0.02 ml. of a supernate from homogenate
centrifuged at 500g for 10 minutes, and the latter refers to the same
supernate after it has been frozen and then thawed at a later date.
When preparative procedures depart from these standards the details
will be given.
The mice to be injected were held on a sterilized stainless-
steel platform. This, and other metal stands, instruments and homo-
genisers were sterilized after each usage by four, one hour cycles at
26 p.s.i. (130° C) in a gravity displacement autoclave. Other
glass-ware and syringes which had been used for infected tissues were
disposed of by incineration.
2.3e Incubation Periods and .Related Parameters. Since scrapie
agents cannot be located, measured or characterised by direct
observation and other straightforward techniques, it is necessary to
use the clinical responses of the host as the main indicator of the
progress of the disease. For the i.e. route the dose/inoubation
period response curve for each agent is known very precisely, and as
a result it is often possible to estimate the titre of agent in a
single dilution of a particular homogenate with a high degree of
accuracy using the mean incubation period in about 10 mice. Only in
special cases, therefore, is it necessary to conduct a full
log-dilution titration which requires at lea3t 400 days, and about
50 mice.
"Incubation period" can be loosely understood in various
ways, but in these laboratories it is measured using rigidly defined
criteria (Dickinson, Meikle & Eraser, 1968). Injected mice are scored
once a week during the afternoon on a day in which no husbandry
routines have previously been carried out. Each mouse, individually
identified by cage number and ear notches, is classified as
•unaffected', 'possibly affected* or 'definitely affected* with
certain specified clinical signs of scrapie and the scoring is done
•blind* - that is without knowledge of how eaoh individual mouse has
been treated. Sooring is performed by trained assistants, whose day
to day familiarity with the particular strain of mouse in both health
and disease, especially fits them for making these assessments. The
end-points for calculating the inoubation period are defined as the
day on which an uniinal receives a third consecutive weekly score of
'definitely affected* or the day on which a fourth such score is given
within five consecutive weeks, or the day on which it is killed
in extremis with scrapie, if less than two weeks after its first
definite scrapie score, or it is found dead having received a
•definite scrapie' score during the previous 7 days. This is a
buffered system giving results that show a normal distribution about
the group mean, (except at limiting dilutions when there is skewing),
- 31 -
which permits the valid use of conventional statistical techniques.
There are some other important parameters which are derived
from the incubation period data. They are, the P/C ratio, the p/s
ratio and the degree and direction of the dominance of the alleles of
sine with respect to eaoh agent* s incubation period.
P/C ratio Incubation period after i.p. route (days)' incubation period after i.e. route (days)
Values for this ratio range from 1.2- 2.0 for a \% homogenate
(Dickinson & Outram, 1973 and Dickinson, pers. comm).
p/s ratio - iaoubation Period in VM mice (p7p7) (days)
incubation period in C57 mice (s7s7) (days) using same
route. Values for this ratio range from 0.42 - 2.56 for the i.e.
route (Dickinson, 1970; Dickinson & Meikle, 1971).
The differences in degree and direction of dominance of the
alleles of sino are illustrated by the incubation period values in
Table 2.1.
2.3f Lesion Profile. This is the second important parameter
developed in these laboratories for measuring host response to scrapie
infections (Fraser & Dickinson, 1968; Fraser & Diokinson, 1973).
It is a method of measuring and expressing the distribution and
intensity of grey-matter vacuolar lesions as they occur in nine
selected regions of the mouse brain. It provides an objective, over¬
all description of lesion distribution, which can be shown to depend
upon a variety of factors. In every instance that has been fully
analysed (which now amounts to 5 agents) any agent that can be
distinguished using the incubation period parameters, can also be
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distinguished by its lesion profile. Thus it provides an independent
method of checking agent identification. This lesion profile,
unlike the absolute incubation period, is not affected by the dilution
of the inoculum; with the ME7 agent this finding has been established
for doses over 6 orders of magnitude. Although it is unaffected
by the precise site of injection in the brain (Fraser, 1971), the
lesion profile for a particular agent can be significantly changed
by a number of other factors. These include the strain of the host,
the strain of the donor, the infected tissue used (spleen or brain)
and the route of injection (Fraser & Dickinson, 1970; Fraser, 1971)•
The fundamental bases for these differences in lesion profiles, such
as that of the relation between lesions and the distribution of agent
or cause of death are still unknown.
The histological scoring procedures are as follows:
five transverse paraffin sections, 7 microns thick, prepared from each
brain by the method of Mould, Dawson, Slater & Zlotnik (1967) are
stained with haematoxylin and eosin. Nine regions of grey-matter are
examined for degree of vacuolation, namely (1) the dorsal medulla;
(2) the folia of the cerebellar cortex (nodulus); (3) the superior
colliculi; (4) the hypothalamus (generally); (5) the thalamus
(central); (6) hippocampus; (7) the paraterminal body (septum);
(8) the posterior cerebral cortex in the region dorsal to the corpus
oallosum; and (9) the anterior cerebral cortex at the level of the
septal nuclei. Each area is given a score from 0-5 depending on the
degree of vacuolation which is present. The five degrees of brain
damage may be verbalised as follows: (l) a few vacuoles, widely and
unevenly scattered; (2) a few vacuoles, evenly scattered; (3) moderate
number of vacuoles, evenly scattered; (4) many vacuoles with some
confluence and (5) dense vacuolation with most of the field confluent,
A useful approximation of the degree of vaouolation is the total
lesion score and is obtained by summing the average values of the 9
individual lesion scores. All sections are examined and scored
•blind' and in random order.
Lesion profiles are based upon grey-matter vaouolation.
Some agent/host strain combinations also show a degree of white-matter
vaouolation which is referred to as "oedema" for simple distinction.
It is possible to distinguish with a high degree of efficiency between
scrapie lesions and oedema due to age.
Reference standards for incubation periods and lesion
profiles, using the methods outlined above, are now available for
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DEmOFMKNTAL MATURATION OF SUSCEPTIBILITY TO SCRAPIE IN ?.:iCE
When newborn mice are injected by the i.e. route with standard
supernates of ME7 scrapie, the incubation period is virtually the
same as that after the same dose and route of injeotion in weanlings,
because the reduction of incubation period with increasing age at
injeotion is very small: b = -0.05 ± 0.01 days/day over the range
0-130 days of age for the ME7 agent in C57 mice (Dickinson & Meikle,
1971)• To the extent that shorter incubation periods are an
indication of greater susceptibility, this is an unexpected result,
since one would normally expect neonates to be more rather than less
susceptible to an infeotion than older animals. This negative
regression is manifest moreover, even though the neonates receive a
much higher dose in proportion to body weight than weanlings.
However, when newborn mice are injected with scrapie using the i.p.
route. very different results are obtained from those of weanlings.
Previous to Outram, Dickinson & Fraser (1973) other published attempts
to investigate the effect of age upon the incubation period of
peripherally injected scrapie agent showed that no difference could be
detected using mice as young as 6 days old (Kimberlin & Killson, 1972).
When, however, standard scrapie supernates are injected by the i.p.
route into mice during the first three days of life, the incubation
periods are generally very greatly lengthened, with a proportion of
animals that do not get scrapie at all. (There is in addition a small
proportion of mice with incubation periods that are signifioantly
shorter than those amongst weanlings: an untidy-looking feature
whioh may, however, be important for a proper understanding of the
phenomenon).
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Special procedures for injection in neonates
For the injection of newborn mice a number of special
precautions were taken in order to minimise the possibility of losing
inoculum by leakage. Y/hen animals were less than a week old at the
time of injection, a fine (32G) hypodermic needle was used and inserted
into the peritoneal cavity from a point of entry near the liver having
run a short way subcutaneously from near the xiphisternum. The
injection site was then sealed with Nobecutane acrylic solution.
Ex. 3.1 Tables 3.1 and 3.2 report the results of using three agents
(ME7, 79A and 22A) in three strains of mice (C57, VL and VM) with ages
ranging from birth to 28 days (weaning normally being on the 21st day).
Three different concentrations of standard supernates of infected
-1 -2 -3




Because the means and variances of the incubation periods in
the different agent/host strain combinations differ so much from each
other the results have been expressed in Table 3.2 in terms of Standard
Deviations (SD) on either side of the mean incubation periods, in
weanlings, for each agent/host strain/sex combination. For more
efficient estimates of these standard deviations than could be obtained
by using only the results from the weanlings in these experiments,
they were calculated after adding the values of incubation periods
from other oomparable non-contemporary replicates. These pooled
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results are shown in Table 3.1. The incubation periods of the
contemporary and non-contemporary weanling control groups were closely
similar to each other.
Table 3.1 The incubation periods shown by weanling mioe












22A VM 10"2 27 31916 35515
79A VL 10"2 38 20511 21512
ME7 C57 10'1 15 22514 23313
CM1
o 36 24912 250+4
1
o 11 278+6 27513
However, it can be seen that in the case of mice that were
injected in the first few days of life, numbers of individuals showed
very wide deviations from the mean. There is a complication,
however, due to an interaction with dose as indicated by the ME7
results. These suggest that cases following a neonatal injection
tend to occur earlier than weanlings with the high titre inocula, but
later with the low titre inooula. In accord with this trend,
survivors only occurred in the newborn group of C57 mice when given
the lowest titre of ME7 agent. The proportion of survivors using
10 homogenates was higher in the case of the other two agent/host
strain combinations than for the ME7/C57 combination. Animals were
regarded as 'survivors' if they either died or had to be killed
without clinical signs of scrapie at more than 550 days old.
Table3.2hdistri utionofinou atiperiodsthreescrapieagentsinjeo d.p.nm cf differentages.Thindividuali cubationperiodsareclassifiednte most nd rviati s fromthemeaninoubationperi dnw lingice
Agent 22A ISA
Mouse strain VM VL
ME7C57BL
Dilution






































































survivors 3 8 9
animalsinjectedwiths rapiebutdyingorh vintkillf nicalco ditionso rthscrapie atmorethan550d ysold. SD=tandardDeviation.
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Depending on the particular agent/host combination this age represents
individuals with incubation periods more than 10 to 50 SD later than
the mean for weanlings. In addition, these survivors were found
histologically to have no scrapie lesions.
Ex. 5.2 Modification of the neonatal age-effect in VI mice with
79A scrapie by the addition of adult bone-marrow and thymus cells
to the inoculum.
As a test of whether or not the lymphoreticular system is
involved in the neonatal age-effect, an attempt was made to modify it
by giving mice in the age-range 0-20 days a scrapie inoculum i.p. to
whioh had been added living bone-marrow and thymus cells. This type
of mixture of B- and T-cells has frequently been shown to be effioient
in the restoration of immunocompetence to mammals after various kinds
of experimental manipulations like thymectomy, sub-lethal irradiation,
tolerogenic regimes etc. (Claman & Chaperon,1969; Playfair, 1968;
Miller & Mitchell, 1968; Mitchell & Miller, 1968; Nossal et. al., 1968).
Such a mixture, which was not washed, probably also oontained some
physiologically active substances like thymosin (Trainin et. al., 1969)
but these would be rather unlikely to have any effect in a single
small dose.
Procedures The cell suspensions were prepared by washing out the
contents of both femurs of 3 weanling and 4 five week-old VL female
mice using 2 ml. of ice-cold Hank's balanced salt solution (HBSS).
1.75 ml. of this suspension was mixed immediately before injeotion with
the same volume of a thymus cell suspension prepared by gentle teasing
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in another 2 ml. of cold HBSS and taken from the same animals.
Viability, using the Trypan blue exclusion test was 80$,
This cell suspension was then mixed with an equal volume of
-2
a 2 x 10 standard 79A brain supernate which had been prepared from
a terminal RIII female brain using HBSS for suspension instead of
saline.
62 female and 61 male VL mice ranged from 0-21 days old
were injected i.p. with 0.02 ml. doses of this mixture, taking the
usual precautions against loss of inooulum in those less than one
week old. Contemporary controls were 5 ten-day old and 3 four-day
old VL mice injected i.p. with 0.02 ml. of the 79k supernate diluted
with HBSS only (i.e. no cells). (Also some mice were injeoted with
the cell suspension only to check for the absence of infection in
these inocula).
Results The incubation periods of the controls indioated a normal
titre of 79A agent and therefore validated a comparison with large
non-contemporary groups of VL mice which had been given 79A i.p. and
covering the same age-range but without any cell-treatment. The
percentage incidence of individual incubation periods in the standard
deviation groups about the means of VL mice of different ages are given
in Table 3.3.
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Table 3.3 The incubation periods of 79A i.p. in VL mice of
& b
various pre-weaning ages, with or without the
addition of lymphoreticular cell suspensions.
















18-20 12a 17 25 58 0 0 0
42b 0 5 90 5 0 0
6-15 42 5 14 81 29 0 0
45 0 16 58 27 0 0
3-5 20 10 0 30 60 0 0
16 0 0 62 31 6 0
0-2 26 22 6 22 39 11 0
33 6 3 21 21 24 26
£
The first line in each age group gives the values after
cell-treatments.
b
The seoond line gives values without cell-treatments.
This comparison of the incubation period distributions obtained in
age-experiments with and without treatment with adult lymphoreticular
and haemopoietic cell suspensions shows that such treatment reduces
the neonatal resistance to peripherally injected scrapie and increases
the proportion of early cases. These effects are most apparent in the
first two weeks of life, but continue less strongly up to the time of
weaning.
It should now be possible to identify the particular factor
or factors responsible for this effect. Clearly it could be due to
a number of possible causes such as, a general activation of the
neonatal peritoneal cell populations by the adult tissues, or the
addition of particular cell populations, missing from the newborn
mouse but required directly for scrapie pathogenesis, or a premature
development of the necessary oells brought on by hormones in the
inoculum (e.g. thymosin, Trainin et. al., 1969). A rather less
interesting possibility is that a hastened maturation may have been
caused by a mild infection due to some conventional virus in the
inoculum, although no sign of such an infection was seen in the
animals injeoted with bone-marrow and thymus cells only.
There i3 no way yet of choosing between these possibilities,
although my inclination, in view of the involvement of the agent with
lymphoreticular tissues, is to suspect that the treatment worked by
contributing one or more of the necessary cell populations. Further
experiments using sub-populations (and later perhaps, mixtures of
sub-populations), cell-free extracts and tissues from other organs,
are in preparation.
A small experiment already performed is of interest in
this context. Adult peritoneal macrophages (stimulated by
thioglycollate 8 days previously) were given i.p. to a newborn litter
of VL mice two days before an i.p. injection of 79A scrapie. This
treatment apparently prolonged the incubation period (247 ± 6 days)
beyond what is usual for this age (227 ± 5 days) P = 0.02, with the
production of two survivors which were negative both clinioally and
histologically at 600 days. If this observation is substantiated on
a larger scale and using more elaborate controls then it will be
evidence for a scrapie inactivation capacity of macrophages.
SECTION 3 DISCUSSION: INFLUENCE OF THE STATE OF DEVELOPMENT ON THE
INCUBATION PERIOD OF PERIPHERALLY INJECTED
SCRAPIE.
The range of results in this SECTION could be important for
the future investigation of the pathogenesis of scrapie in mice.
There are several possible explanations for them such as the production
of some form of neonatal tolerance, or massive excretion of the agent,
but the most likely is probably that neonatal mice lack one or more of
the cell populations that are required for the initiation of scrapie
pathogenesis by the peripheral route. The possibility of tolerogenesis
is examined in SECTION 4 but no evidence of it has been found.
Hypotheses about the cause of this neonatal age-effect on
the basis of cellular immaturity need to aocount for the disposal of
agent activity before the relevant oells develop and for the
observation that early cases do in faot occur, in line with what one
would expect in conventional virus infeotions, and this can apparently
be encouraged by simultaneous injections of adult bone-marrow and
thymus cell suspensions, or by using higher titres of agent. In other
words, they must account for the paradox that the inoubation period
data in neonatal mice would give lower estimates of titre than in
weanlings, but with shorter incubation periods than weanlings at the
higher doses. Complete titrations at different ages are at present
in progress in these laboratories and will therefore provide more
adequate data to illustrate this point.
Perhaps the simplest theoretical condition to meet the above
requirements is that there are at least two sets of relevant cell
types (or systems within one cell) that are developing at different
rates in newborn mice, and that individual differences in their
relative maturation at this unstabilised stage are responsible for
individual variations in incubation period. Thus, if there were two,
antithetical conditions in the host - one favouring the replication
of the agent and the other causing a loss of activity - then individual
differences in the rate of development of one or other would interact
with the concentration of agent administered to give a wide array of
incubation periods ranging from the very short to the very long as
compared with those of mature animals in which the proper balance of
functions had been achieved.
At a higher level of complication the requirements referred to
are met by a model employing three sets of relevant cell types: the
above mentioned two and a third with the role of transporting the agent
from the first to the second - a process whioh is normally accomplished
before there has been much inactivation. Immaturity of this type of
cell in neonates would also facilitate inactivation and frustrate
replication of peripherally injected agents, while premature development
could result in shorter incubation periods than in weanlings.
The necessity to postulate some system for the inactivation
or excretion of the agent comes from the known high resistance to
physical or chemical inactivation of scrapie (Stamp, 1967) which would
otherwise lead one to expect that agent could persist - for weeks if
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neoes3ary - in the body of the young recipient, until the necessary
reoeptors matured and replication could commence. While something of
this sort would clearly account for prolonged incubation periods such
as occur, something else must be involved in the case of survivors.
There is no realistic possibility that these results could be due to
the loss of the inooulum by leakage, because the values for the long
incubation periods would require the loss of nearly all of it and
specific precautions were taken. If it is oorrect, therefore, to
oonclude that one or more relevant sets of receptor cells for
replication are absent in the newborn mouse, three possibilities must
be considered for the fate of the agent. It could be effectively
disposed of by exoretion (e.g. through the gut wall which is permeable
to several macromolecules at this stage), or by sequestration in some
alternative tissues where it cannot replicate, do damage or gain access
to target cells, or thirdly, the agent could be inactivated enzymically,
for instance by macrophages which presumably have somewhere in their
armoury a means of dealing with any organic molecule. Excretion
through the gut wall i3 perhaps the least likely and is argued against
by results desoribed in SECTION 4 where it is shown that large doses
of steroids can potentiate the neonatal age-effect. Such doses of
exogenous steroids are known to cause a premature olosure of the gut
to maoromoleoules which would presumably apply also to scrapie
(Daniels & Hardy, 1972).
This potentiating effect of steroids also supports the other
two possibilities: sequestration and destruction by macrophages.
With this type of model, the longer incubation periods and the
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survivors amongst neonates would be accounted for by postulating that
the disposal system normally developed before the one favouring
replication, so that with sufficiently low titres of agent most or all
activity could have been removed before the scrapie-supporting tissues
had time to mature. Support for the notion of a peripheral system
inimical to scrapie replication also comes from the operationally
lower estimates of titre obtained in mice injected after weaning by
the i,p. route as compared with the i.e. one.
Of the mary systems that are still developing in the
neonatal mouse the lymphoretioular/haemopoietic system is a very
likely one to be involved. Other studies on the age-dependent
susceptibility of mammals to virus infections have implicated various
cells of this system, particularly the macrophages (Johnson, 1964;
Goodman & Koprowski, 1962; Gallily et, al., 1967; Kantoch &
Dobrowolska, 1969; Hirsch, Zisman & Allison, 1970), The contrast
must, however, be emphasised between these systems, where the
immaturity of components of the lymphoreticular system renders the
individual generally more susceptible, and the case with scrapie
where the reverse applies, and in which, if these tissues are involved
they would assume the role of a Trojan horse in which the agent could
replicate and perhaps be transported unhindered and undetected by the
host.
The normal development of the lymphoreticular system is
also related to the complex process of the acquisition of immunological
competence (Argyris, 1968; Tyan, 1968; Tyan & Herzenberg, 1968;
Claman & Talmage, 1963; Playfair, 1968a). In most age-dependent
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susceptibility situations it is possible to explain the findings in
terms of the involvement of the normal immune response, but this seems
most unlikely in the case of scrapie to which no specific immune
responsiveness has ever been certainly demonstrated. It is possible
that scrapie agents may be capable of using some kinds of weak host
immune responses without provoking reactions specifically against
themselves, SECTION 6 describes a system in which antigens
probably of donor-origin in the homogenate may be able to influence
the course of pathogenesis in such a manner as to suggest that the
agent is making U3e of specific host responses to these donor
antigens.
An important phenomenon which this neonatal age-effect may
eventually help to explain is that while there is clear evidence for
maternal transmission of agent in sheep (Cordon, 1960; Dickinson, 1967;
Dickinson, Young, Stamp & Renwick, 1965) there is considerable evidenoe
against its occurrence in mice (Clarke & Haig, 1971; Dickinson,
unpublished). It may be significant that while sheep become immuno¬
logically responsive to several antigens many weeks before birth
(Schinckel & Ferguson, 1953; Prendergast, et, al., 1969) mioe are
immunologically unresponsive at birth. Could the difference in
maternal transmission of scrapie in the two species be due to foetal
sheep having the relevant scrapie receptors somewhere in their
lymphoreticular systems, while mice do not develop them until a few
days after birth?
There is also the possibility that an understanding of the
apparent ability of hosts to dispose of scrapie activity under certain
circumstances could lead to methods of control.
SECTION 4 describes a drug-treatment which seems to mimic
the age-effect in some respects, and further discussion of the
possible role of the lymphoreticular system will be left until the
discussion of those results.
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SECTION A
PHARMACOLOGICAL MODIFICATION OF SCRAPIE INCUBATION PERIODS
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FHARIvIACOLOCrlC-AL MODIFICATION OF SCRAPIE INCUBATION PERIODS
In accordance with the policy of trying to detect eritioal
phases in the pathogenesis of scrapie agents by looking for ways to
modify their incubation periods, particularly after peripheral
injections of agent, a range of pharmacological treatments has been
tested l^y means of pilot experiments. Of the several positive
findings, one has been developed as a series of second generation,
and to a certain extent third generation experiments. Drug treat¬
ments that gave negative results in pilots were not investigated
further, although in the light of the positive results to be described,
some of them will need to be re-examined using different doses and
regimes.
Two prominent considerations attach to designing experiments
for the investigation of scrapie pathogenesis by pharmacological
means. The first concerns the choice of drugs, and the second
relates to the dose, regime and timing of treatment with respect to
the scrapie injection.
As to the ohoioe of drug, this must be determined by what
seems at the time to be the nature of the agent and its manner of
interaction with the host. Sorapie agents apparently replicate
peripherally in the tissues of the lymphoretioular system where the
time of the onset and possibly the rate of replication is under the
close control of the sine gene. (Dickinson & Eraser, 1969). One
choice of drugs therefore is that of substances known to upset normal
lymphoreticular funotions for which various immunosuppressants are
obvious candidates. Amongst these are drugs which interfere with
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normal nucleic acid metabolism and although the question of whether or
not scrapie agents contain nucleic acid3 has not been settled, they
clearly could do so, and in ary case may depend fairly directly upon
the normal function of host nucleic acids for their own replication
and/or pathogenic action.
respect to the scrapie injection arises because of the unusually long
incubation periods as compared with those of conventional pathogens.
Most of the published data on the doses of relevant drugs in mice are
based upon short-term treatments after whioh the animals are usually
killed, so that long-term effects are often not known. For example,
Stenram & Nordlinder (1968) have shown that if, instead of being
saorifioed quickly, rats are kept after treatment with cyclophosphamide
(65-110 mg/kg body weight) they usually die after about three months
with a wasting disease. Long-term treatments with drugs have other
disadvantages. It is difficult to judge the level of dose which
might be enough to modify scrapie pathogenesis but which will neither
harm the host nor allow it to develop effective detoxicating enzymes
or antibodies. The most hopeful type of treatment whioh might
change the incubation period would be one in which as high a dose as
possible was given for a period of two or three weeks at a time
critical for agent replication. Two such periods are probably
relevant: one shortly after a peripheral injection when a relatively
rapid increase in titre occurs in lymphoreticular tissues, and a
second about half way through the incubation period when there is a
sudden change in brain metabolism accompanied by the appearance of
The question of the correct dose, regime and timing with
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lesions and a clearly detectable rise in titre. (Numerous references
reviewed by Kimberlin, 1973). An interference with agent replication
by a short burst of drastic treatment at the beginning of the
exponential phase of increase would be more likely to be projected as
a change in incubation period than would an attempt to interfere
continuously with replication using ohronic treatment at lower doses.
The practical question therefore, of what doses to use in
pilot experiments was answered by using published dosages as a guide
and then increasing or decreasing them appropriately to suit a course
of two or three weeks intensive treatment, and finally monitoring the
mouse response by taking body weights and observing behaviour generally.
This procedure sometimes resulted in short-term or long-term death
from toxic effects, and sometimes in an underestimation of the dose
required to affect scrapie despite this general approach. As will
become apparent in the aocount of the experiments involving
prednisone acetate the question of dose oan be very critical indeed
and it may be that some of the negative results listed in Table 4.1
reflect a failure to find the correct regime rather than an
inefficacy of the drug.
RESULTS OF EXPERIMENTS SHOWING- NO EFFECT OF DRUG TREAT!,ISNTS ON
SCRAPIE INCUBATION
Ex. 4.1 Drug treatments that showed negative results are listed in
Table 4.1. These are dismissed briefly since it would be tedious to
desoribe them in full only to be left with uninterpretable negative
results.






Streptonycin 2ug i.p. 2 x week for 5 weeks,
starting 7 weeks after 79A
i.o. A2G-





25mg/kg in 100$ DMSO i.p. daily for
3 weeks after 79A
i.p. C3H, A2G
25mg/kg in 100$ DMSO i.p. 3 x week from i.o. A2G-
60-90 days after 79A
Rifampycin Estimated 50mg/kg/daily oral in drinking
water throughout incubation
i.p. C51, A2G





1Omg/mouse/week in DMSO for 5 weeks
after 79A
i.p. SM, LM (all died)
6-meroaptopurine 200u^mouse/day i.p. 10 x in 2 weeks i.p. SM
200ug/mouse/day 25 x in 5 weeks, i.o. A2G
starting 7 weeks after 79A
Caffeine 1mg/kg i.p. 20 x in 4 weeks after 79A i.P. Porton mioe
Actinonycin D 1 ug/mouse/day i.p. 10 x in 3 weeks
starting 2 days before 79A
i.p. BALB, RIII, SM, C3H
Cyolophosphamide 2.5mg/kg daily for 2 weeks i.p. C3H
100mg/kg i.p. 3 days before 79A; 6 daily i.p. RIII
prednisone 50mg/kg starting 7 days
after 79A
PREDNISONE ACETATE (PA)
Very marked effects upon scrapie incubation periods have
been obtained using this drug and most of this SECTION will be devoted
to describing experiments which explore this effect. A single
subcutaneous (s.c.) injection of cortisone acetate (400-500 mg/kg) in
8-12 week-old Swiss white mice depresses the serum haemolysin response
to sheep erythrocytes when administered near the time of antigen
injection, but especially 3-4 days previously. It causes a reduction
in the levels of antibodies (both 19S and 7S); in the numbers of
circulating lymphocytes and monocytes; in the weights of the thymus,
spleen and lymph nodes. Polymorphonuclear leucocytes (PMN) fall to
of normal on the 1st day, recover to control level by the 4th day,
overshoot to twice the control count by the 10th day, then return to
normal by the 40th day (Elliott & Sinclair, 1968).
In view of the association of peripheral scrapie replication
with the lymphoreticular organs it was decided to base a pilot
experiment upon this type of protocol. In addition, although it
seemed possible that a single injection as described would be
sufficient, it was decided to try to maintain the depressed state
produced by the large dose by adding a follow-up course of steroid
injections at a lower individual dose. A potentially better steroid
than cortisone for this sort of treatment is the artificial
glucocorticoid, prednisone acetate (1,4--pregnadien-l7,2l-diol-
3,11,20-trione 21 acetate). This has about three times the
glucocorticoid effects of the natural steroid but with greatly
reduced mineralocorticoid effects and thus is more suitable for large
and prolonged doses.
- 54
;x. 4.2 ^edniaone acetate pilot experiment
15 adult VL cice were treated with PA or saline before end
after an l.p. injeotion of standard 79A frozen brain supernate.
Three days before the scrapie injection the 9 experimental oniaala
received 250 rag/kg Pa in 0.1 ml. saline s.o. Then on days 18, 21,
25, 28 and 32 after the scrapie injection they received 12.5 mg/kg
doses of PA s.o. The 6 control mice were given saline injections
e.c. There was no further treatment and the disease was left to
run its normal course. All the mice developed scrapie and their







Controls (saline-treated) 209 t 2 206-239
Ixperimentals (PA-treated) 273 t 39 204-527
Three of the experimental animals showed incubation periods
within the range of the controls, but five of them had considerably
prolonged incubation periods. This was therefore a very promising
result although the high variance ratio prevented an assessment of
significance using simple tests (Snedeoor, 1946).
The most immediate question to arise was whether the steroid
acts by interfering in some way with agent replication or by changing
the threshold of host responses so that it can survive much higher
levels of agent concentration in its tissues. Accordingly the
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spleen was removed from one of the females in this experiment, killed
with no clinical signs of scrapie 338 days after the scrapie injection.
k '[Ofo saline spleen homogenate was prepared and injected without
oentrifugation by the i.e. route into C57 mice: none of these had
developed scrapie 680 days later and were also found to be negative
histologically. This result suggests that the steroid interferes with
the initial stages of peripheral pathogenesis so that there is a
failure on the part of the agent to reach some or all peripheral
replication sites. This resembles closely the demonstration by
Nettesheim and Hammons (1970) that several immunosuppressants,
including cortisone acetate interfere with the normal accumulation of
peripherally injected antigens in the spleen.
It should be appreciated that a period of over 1000 days had
lapsed between the start of the PA pilot and the final demonstration
of the absenoe of scrapie in the C57 assay animals. In the meantime
a considerable programme of follow-up experiments was mounted using
the tactical approach outlined in SECTION 1. These will now be
described in an order chosen for clarity rather than historical
accuracy. As a result it will sometimes appear that certain
inappropriate experimental procedures were still being used long after
they should have been dropped, because early experiments are being
reported after later ones. One particularly striking illustration
is perhaps best described at this junoture. A3 a result of the high
variance in the incubation periods of the pilot experiment it was
decided to suspend the PA in arachis oil, rather than in saline, in
order to ensure uniformity of dose in case this was the cause of the
variation in response. Arachis oil was chosen since it was in use
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in commercial preparations of other steroids. Many of the follow-up
experiments employed this 'neutral* vehicle and it was not until a
year and a half later that it beoame apparent that the arachis oil
itself had a marked prolonging effect on incubation periods of
peripherally injected scrapie. It was immediately replaoed by 2fo
Tween 20 in saline as the suspensory medium, and of oourse, became a
substance of interest in its own right. However, this was not
discovered before it had rendered several experiments partially
uninterpretable at least in the terms under which they had been
designed.
Kx« An. attempt to repeat and extend the PA pilot result including
a test of its effect on i.e. injected agent.
This repeat used larger and more intensive courses of
injections of PA, slightly older animals and higher doses of agent
than the pilot. Some animals received the sorapie injection by the
i.e. route.
13 and 6 female VL mice received, respectively 0.1 ml. i.p.
or 0.02 ml. i.e. of standard 79A supernate. The mice were treated
with PA in saline or saline only (controls) in the following manner.
Four days before the scrapie injection 7 of the females (to be given
i.p. scrapie) and 3 of the females (to be given i.e. scrapie) were
injected s.c. over the shoulder with the equivalent of 500 m^kg of
PA in 0.1 ml. saline. Beginning seven days after the scrapie
injections these animals were given 11 daily equal doses of
100 mg/kg each of PA s.c.
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i.p. injected controls 207 ± 8
<0.02








* omitting a single early value of 179 days
These results show no evidence that intensive courses of PA
at the time of injeotion can influence the pathogenesis of i.e.
injected agent. The incubation periods of the i.p. injected group
confirm the pilot results and on this occasion the variance ratio of
the two groups is low enough to permit the calculation of the
significance of the effect using a simple t test. The effect of the
PA on incubation period was, however, less marked than in the pilot
despite the much higher doses. The two protocols differ in the
following respects:
the mice in the pilot experiment were 32 days old, and those
in the repeat 35-60 days old at the time of scrapie injeotion;
the timing and dose of steroid was different, with a total
of 312.5 mg/kg in 5 weeks in the pilot, and 1600 mg/kg in 3 weeks in
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this experiment;
- the incubation periods of the controls indicate that the
titre of the 79A in the frozen supernate material used in the pilot
was about 1 .5 log LD^ units lower than that of the brain pool material
used in this experiment.
The previous SECTION showed how age of host and titre of
agent can interact in a complex way to influence the incubation period
and it is possible that something of the kind is happening here too.
The lack of effeot on i.e. injected agent could be due to
either (a) failure of the steroid to reach the necessary concentrations
in the brain in order to react effectively with either the agent or
the relevant host mechanisms, or (b) the absenoe from scrapie
pathogenesis in the brain immediately after an i.o. injection of one
or more steroid-sensitive steps obligatory in peripheral
pathogenesis.
Ex. 4.4 Three experiments to investigate the effeot of using
very young (unweaned) VL mice in PA experiments
It was appreciated quite early in the series of PA experiments
that the drug appeared to produce in adults an effect on incubation
periods similar to that of the neonatal state. Three early
experiments investigated the effect of using the original PA regime
on unweaned mice. All three used frozen homogenates of agent as
was the practice with small groups of animals (see SECTION 2).
Litters of VL mice aged 3, 6 and 13 days old were injected
s.c. with 250 mg/kg doses of PA in saline or with saline only. Pour
days later all mice received i.p. injeotions of 0.02 ml. standard
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79A frozen brain homogenate. Then, beginning 17 days later, the
experimental groups received 6 follow-up doses, eaoh of 12.5 mg/kg
PA in saline, on days 17, 20, 24, 27 and 31.

























* clinically negative animals found to be histologically negative
These results show that unweaned mice are more sensitive to
the effects of this PA regime than weaned mice are, even to the
extent of producing survivors among mice injected at 10 days of
age. (cf SECTION 3). The very great spread of inoubation in the
7 day olds was, however, quite unexpected, and since at the time we
were not yet reconciled to its occurrence in the neonatal age-effeot
the result seemed to be anomalous. However, as will be
illustrated by other experiments in this SECTION, such very early
cases are a feature of the PA-effeot in very young mice and may be
caused by a steroid-induced physiological state similar to the one in
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neonates which also results in very short incubation periods as
compared with weanlings.
Ex. 4.5 Two experiments to investigate the effect of varying the size
of the initial dose of PA on the inoubation period of 79A
in weanling TL mioe
Some of the early follow-up experiments were attempts to
see if large PA injections given a few days before the sorapie
injection were in fact all that was necessaxy (as in the immunological
•model' of Nettesheim and Hammons, 1970) and if so, what dose would
be necessary. These experiments also used arachis oil as a
vehiole.
In one experiment, VL mice were given 1-3 i.p. injections
each of 500 mg/kg PA suspended in arachis oil during the three days
preceding a standard 79A injection i.p. In another experiment,
they received either 500, 250 or 50 mg/kg PA in arachis oil i.p.
three days before the standard 79A injection i.p. Thus the PA
dose in these two experiments ranged from 50 to 1500 mg/kg
immediately before the scrapie injection. In the second experiment
some controls were injected with oil and the others were completely
untreated. Neither experiment employed maintenance doses of PA.







Three pre-treatments with oil-only i.p. 197 ± 1
500m^/kg PA in oil i.p. on day -1 197 ± 2
Total of 1000mg/kg PA in oil on days -1 & -2 *181 ± 16
Total of 1500mg/kg PA in oil on days -1, -2 & -3 200 + 0













Females 185 ± 2 195 ± 4 195 ± 3 199 ± 7 197 ± 4
Males 194 ± 8 197 t 7 214 ± 4 206 ± 7 216 ± 4
The probability that the difference between the incubation
periods of the female uninfected controls and the females pre-treated
with arachis oil is due to chanoe is greater than 5$» and the
addition of PA did not increase the significance of the difference,
but the trend is consistent. Similar conclusions apply to the male
results.
These values show that single injections of PA in oil i.p.,
even when very large doses are used do not greatly affect the
incubation period of 79A in weaned VL mice. Some of the problems in
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this kind of work are well illustrated in this experiment. The
emergence of a large sex difference in the second experiment was not
anticipated at the time of the design and resulted in a great
reduction of the intended group size. Also, no significance was
attached at this stage to the araohis oil control results so that
this vehicle continued to be employed in subsequent experiments.
Ex. 4.6 Two experiments using a testosterone treatment of YM mice
with 22k agent to see if it would increase the sex-effect
and/or produce results similar to PA
The agent/host strain combination of 22k agent in VM mice
using the i.p. route of injection was discovered to show a marked
3ex-effect with the males having a longer incubation period than
females (Dickinson & Meikle, 1969 an<l APPENDIX 3) • Experiments
using sex-steroids were therefore undertaken to see if they would
throw any light on the matter and also to see if steroids other than
glucocorticosteroids would also affect scrapie incubation periods,
especially since the sex steroids also have effects on the size and
immune functions of the lymphatic system (e.g. Frey-Wettstein &
Craddock, 1970). The results of these experiments will be described
very briefly only since no effect of sex-steroid treatment was
detected but they provided the first clear indication that arachis
oil has an independent effect of its own.
In the first experiment, VM mice were treated with courses
of testosterone phenylproprionate in arachis oil, or folliole-stimulating
hormone (FSH) in saline, or saline only over a period of three weeks
straddling a mid-course i.p. injection of 22A agent. The incubation
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Females 295 i 3 300 t 4 >0.1 CO+1CM <0.01
Male 3 313 t 8 310 ± 9 >0.1 353 ± 6 <0.01
The FSH-injections had no effect on the incubation periods
in either 3ex, The testosterone result, however, seemed at the time
to be highly significant. Its effect had been detected several
weeks before the end of the experiment by a delay in the time of loss
of body weight in these groups (APPENDIX 1) suggesting that the onset
of some stage of pathogenesis had been postponed a few weeks.
However, it was not possible to discount arachis oil as the active
ingredient, although this seemed very unlikely at the time.
(Previous experiments in these laboratories using i.p. injection of
ethylpalmitate had not produced significant changes in incubation
periods which might result from lipid blockade of macrophages etc.:
Fraser, pers. oomm.).
In the seoond testosterone experiment using female VM mice
infected with 22A agent and similarly treated with oil suspended
testosterone also included both arachis oil-treated and untreated















This result shows clearly the effeot of the araohis oil
alone. Although the mean incubation period of the 3teroid-treated
group is longer than that of the oil-treated controls the high
variance ratio makes a significance test unreliable.
Ex. 4.7 An experiment to test the effeot of a single large PA
injection on the day of birth on the inoubation period of
79A injected i.p. a week later
The 7th day of life lies outside the age range for the
production of survivors from i.p. injections of standard supernates of
79A scrapie in untreated VL mice (SECTION 3)• The neonatal
age-effect could be due to the post-natal depression of lymphoreticular
tissues associated with changes in glucocorticoid levels in early
post natal life (Burton & Jeyes, 1968; Philpott, Zarrow & Deneberg,
1969). If 80, an injection of a depot of PA may be able to maintain
this state for longer than just one or two days and produce survivors
in older animals.
A newborn litter of 5 female and 5 male VL mice was injected
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i.p. with either 500 mg/kg dose of PA in araohis oil or were uninfected.
This dose profoundly retarded normal body growth and caused hair
curling as has frequently been described in rats (e.g. Field, 1957;
Shapiro, 1965). At 7 days after birth all the mioe were injeoted






Untreated controls 223,230,230 244,244
PA/oil-treated 230 -
one killed 55&* two killed 534*, 573*
* clinically and histologically negative
Independent titre control of this frozen homogenate indicated
a 2 log drop as compared with usual preparations. Although the
treatment would appear to have been effective in producing survivors
it is not possible to separate the component effects of age, agent
titre, arachis oil and PA.
Ex. 4.8 An experiment to investigate the effect of a single large
injection of saline-suspended PA. injected s.c,. on the
incubation period of 79A injected i.p. in VL mioe over a
wide age range
135 female and male VL mice ranging in age from birth to
25 days were injected i.p. with 0.02 ml. standard 79A supernate.
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The usual precautions were taken against leakage in animals leas than
one week old (SECTION 3). Four days before this injection the aloe
then aged from 2 -lays upwarda were given 50 &&/kg PA in saline, or
saline only, by the subcutaneous route. No maintenance doses were
given. Animals ware weaned at 21 days.













0-1 263137 248 :40 - - -
6-11 2191 2 22513 21213 21716 <.05 >.t
14-20 2011 2 21116 21212* 21911** <.01 >.1
22-23 2021 1 21315 20612 20716 <.05 >.1
24-25 2081 3 21514 20312 20913 >.1 >•1
4 * in addition tisere were 4 and 2 survivors respectively.
The controls in this experiment showed the typical age-effect
with 79 in VL mice: the neonates having much longer average
incubation periods, with a wide range of individual values and the
occurrence of some survivors. The 6-11 age range had incubation
periods intermediate between those of neonates and weanlings. The
PA-treeted results fall into three groups:
* the 6-11 day group in which the change of inoubation period
was in the direction of shortening (Just significant in the females);
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the 14-20 day group in which incubation periods were prolonged
(highly significantly in females) and with survivors in both males and
females; and
the 22-25 day (post-weaning) group in whioh there was no
effect.
This experiment employed a single relatively low dose of PA
in saline injected by the s.c. route. The shortening or lengthening
effects of this injection according to age are probably the
consequence of a complex interaction between age, steroid and agent
dose and the details cannot be resolved at this stage. Indeed
nothing short of full titrations in mice of both sexes, at various
ages between 3 and 30 days, with and without PA-treatment at various
dose levels would properly sort out any such interactions. (This
would require 2500 animals and more than 2-g- years).
Ex. 4.9 An experiment to investigate the effeot of various lengths
of maintenance treatment with PA after pre-treatment with a
single high dose of PA before a 79A scrapie injection
Experiments so far described illustrate some variations in
the amounts and timing of follow-up maintenance doses, but no
systematic attempt to vary this has been described. There are
numerous possible variations in dose, time of onset, frequency of
administration and period of exposure. In this experiment weanling
female and male VL mioe were used. They were given a single
250 mg/kg dose of PA, suspended in 2$ Tween 20/saline, by the s.c.
route 4 days before a standard 79A injection i.p. and then maintenance
-Re¬
courses, beginning 7 days after the scrapie injection, of 1, 2, 4 or
6 weeks duration. The maintenance doses were given 3 times a week
and each injection was 25 mg/kg PA in 2% Tween 20. Two kinds of
controls were included: completely untreated and animals given a full
course of 2$ Tween 20 in saline injections s.c.






Duration of PA maintenance
1 week 2 weeks 4 weeks
course
6 weeks
Females 19214 19215 201 + 7 206+1 21013 211 + 2
P >0.1 >0.1 <0.05 <0.01 <0.01
Males 19815 20114 22910 21316 *220+3 220+7
P >0.1 <0.001 >0.05 <0.01 <0.05
* or 209±13 with P of difference a >0.1 if a single early case at
166 days with good lesions is included.
These results indicate that Tween 20 has no effeot on its
own. Although significant effeots of the maintenance doses are
shown there is no indication that very prolonged treatments have a
clear advantage over short ones: indeed the largest effect was
obtained with males after only one week of maintenance doses. In
the case of the males also, there is the possibility that the
prolonged courses began to encourage the production of early cases.
This could be explicable in terms of a rebound phenomenon resulting
from an underproduction of endogenous cortisone due to the lag in
recovery of ACTH production after the artificial steroid treatment.
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Evidence that this can happen is shown especially by the numbers of
polymorphonucleocytes in the blood after a single dose of cortisone
acetate (Nettesheim & Hammons, 1970; APPENDIX 2). Another possible
cause of the small effects of the follow-up doses in this experiment,
is the relatively high titre of the sorapie inoculum used.
Again, although there can be no doubt that follow-up doses
are neoessary for the prolongation of scrapie inoubation periods in
adult mice the exact dose and regime which would give the best results
is not known and could be difficult to discover.
Ex, 4.10 Two experiments to test the generality of the PA-effect by
seeing if it will influence the incubation periods of the
ME7 and 22C agents after i,p, injection in VL mice
In the interests of minimising the variables as much as
possible all the PA experiments until recently were done using the
79A agent. An important test of the potential significance of ai\y
scrapie finding, however, is its generality. The agents ME7 and
22C are quite different from each other and from 79A although all
three have relatively 3hort incubation periods in s7s7 mice. They
differ from each other in origin, type of interaction with the p7
allele of the sine gene, the distribution of grey-matter lesions and
especially in white matter vacuolation which is intense with 79A,
slight with ME7 and absent with 22C in VL mice.
Male VL mioe were injected i.p. after weaning with 0.02 ml.
doses of standard ME7 or 22C brain supernates. Four days previously
they received s,o. doses of either 500 mg/kg PA in 2?c Tween 20 or
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Tween 20 vehicle only. Then, beginning two days after the scrapie
injection they were given daily s.o. injections for 2 weeks of
50 mg/kg PA in Tween 20 (or Tween 20 only). During the third week
an attempt was made to facilitate withdrawal by giving only two
spaced injections of 50 mg/kg s.o.




















187 248 t 5
*305 t 10 <0.001
22C controls 263 ± 4




* still not showing clinical signs after 450 days.
6.
includes 3 minimum estimated values for animals which were killed
accidentally when still clinically negative at 328 days: the
real values could well have been higher.
Amongst the ME7 group of agents, 79A shows two peculiar
features: it produces the shortest inoubation periods and causes an
intense white-matter oedema, so it was important to discover if the
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PA-effect was confined to animals injected with this agent. The
above results show that it is not, and by demonstrating the wider
generality of the treatment allow the possibility that it acts at a
fairly primary level of pathogenesis. That the steroid is not
merely affecting a feature peculiar to the 79A agent is supported too
by the fact that the lesion profiles and white-matter oedema levels
in animals that have had their incubation periods prolonged by the
drug are similar to those of controls.
Ex. 4.11 Experiments to determine if the modification of scrapie
incubation periods by PA when injected in very young mice
is due to a permanent change in the host
If one assumes that the effect of PA on scrapie incubation
periods is due to some modification of the host* s physiology, then it
is possible that a steroid treatment which in the adult results in a
transitory ohange would in a neonate cause a permanent one, and that
this is the basis of the greater sensitivity to PA treatment in
younger animals. Two obvious examples of this kind of phenomenon are
the permanent androgenisation of female rats as a result of neonatal
injections of testosterone(Barraclough & Gorski (1961) and the
well-known instances of neonatal tolerance to antigens and viruses
(e.g. lymphocytic choriomeningitis virus, Wiegand & Hotohin (1961) )
with or without the aid of immunosuppressants. The following three
experiments all employed an early immunosuppressive treatment (with
or without an early exposre to the agent also) followed by a later
injection of standard supernates after weaning.
- 72 -
1. If the PA-effeot in weanling mice is soma sort of restoration in
adult life of the relevant neonatal 3tate for scrapie 'resistance',
then it might he possible to retain this state by a series of
PA-treatments between birth and weaning. Three VL litters were
injected on days 0, 8, 15 and 29 with either 500 mg/kg PA in Tween 20
vehicle, or with vehicle only using the s.c. route. Then on the 32nd
day all mice were injected i.p. with a standard 79A supernate.









Controls 171 i 2 169-176 207 ± 1 204-211
PA-treated 177 ± 7 162-184 205 ± 4 176-240
P >0.1
The probabilities that these differences are due to chanoe
is greater than 5)?. The treatment seems mainly to have increased the
variability of the incubation periods but without producing any
survivors. The variance ratio indicates that the probability of the
differences in variance being due to chance are less than 0.001.
2. Another test of the effect on incubation period of steroid treat¬
ments starting in the first week of life is interesting although
confounded with araohis oil effects. Pour VL litters, randomised by
redistribution at birth, were used. Three of them were then treated
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with PA or vehicle in the following manner; eight alternating s.c. and
i.p. injections of either 50 mg/kg PA in araohis oil or oil only were
given to the randomised litters on days 3-9 and 11; one litter
received oil only while the other two received PA. The fourth litter
was untreated at this time. Ten days after birth, the oil-treated,
and one of the PA-treated litters received 0.02 ml. of standard 79A
(frozen supernate). The other PA-treated litter was not injected.
Then 49 days after birth this PA-treated litter and the 4th, untreated
litter, were given 0.02 ml. of standard 79A supernate i.p. The



















10 day control oil 79A *241 t 10 225-259 268,306,335,338490,650
49 day control - 79A CVJ+1-d-CM 202-222 -
PA/oil/early 79A PA/oil 79A 365 365 372,490,534,555591,650,650
PA/oil/late 79A PA/oil 79A 211+4 208-229 -
* only 3 cases.
It oan be seen that the early Pa/oil treatment had no effeot
on the later i.p. injection of 79A on the 49th day of life. Quite
unexpected at the time of these results was the very profound effect
of the oil-only on the incubation period of 79A given on the 10th day
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of life. However, the Pii/oil mixture seems to have been even more
effective than oil alone in producing late cases and survivors.
3. A third experiment to investigate the effect of early steroid on
subsequent 79A injection was as follows. Three VL litters were
randomised at birth and immediately given a s.c. injection of
500 mg/kg PA in Tween 20/saline. The next day they had one of the
following treatments:
- 0.02 ml. saline i.p. (Control 1)
- 0.02 ml. normal brain supernate i.p. (Control 2)
- 0.02 ml. of standard 79A supernate i.p.
All these animals were then given a second i.p. injection of




Croup (calculated from 2nd
injeotion)
Pretreated with PA + saline i.p. 198+2
Pretreated with PA + normal brain 194 t 1
Pretreated with PA + 79A brain 195 i 2
Neonatal treatment with PA together with an early exposure
to 79A brain or normal brain antigens had no effect on the incubation
period of 79A injected i.p. 40 days later (P >0.1).
In none of these three related sets of experiments did the
early treatment have any detectable effeot on the inoubation period
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of 79A given later in adult life. This was true even when the early
treatment was shown to be oapable of modifying the pathogenesis of
scrapie given on the 10th day of life. The prolongation of
incubation periods by the araohis oil treatment is also evident.
Ex. A.12 An attempt to increase the effect of PA on the incubation
period of 79A agent in adult VL mice by adding an
injection of cyclophosphamide
The use of several immunosuppressants in sequence in order
to obtain a greater effect on immune responses is now quite a common
practice, especially in organ transplantation, although the regimes
are generally arrived at by trial and error and with little certain
knowledge of the basis of these synergistic effects. Dukor &
Dietrich (1970) have shown that cortisone and cyclophosphamide are
very effective as immunosuppressants when the antigen is preceded
by the steroid and followed by the cytostatic drug. They suggest
that the cortisone interferes with agent handling and the
cyclophosphamide prevents the production of specific clones of immune
cells. Makinodan et. al. (1970) have further shown that this type
of regime is useful for induoing 'tolerance' to an antigen which is
given i.v. between the two drug treatments. The mechanism here
probably involves a permanent destruction of the specific stem cells
by the alkylating agent as they are engaged in clone formation.
It has been demonstrated in this SECTION that PA alone, if
given in an extended course of injections can interfere with the
normal pathogenesis of scrapie agents in the periphery. Attempts to
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use cyclophosphamide alone, however, were not successful (Table 4.1),
as has also been demonstrated by other workers (see especially
¥/orthington & Clark, 1971). It seemed, however, reasonable to try a
combined treatment with the two drugs to find whether they would act
synergistically to destroy the host's oapacity to support sorapie
pathogenesis in peripheral tissues.
Adult VL mice were treated s.c. with 500 mg/kg dose of PA in
Tween 20/saline and two days later with 100 mg/kg dose i.p. of
cyclophosphamide (CPA) in saline. Controls were given equivalent
vehicle injections. Six days later all mice received i.p. injections
of standard 79A supernate.
Incubation periods were as follows:
Table 4.15
Group Inoubation period P
Controls 205 ± 3
PA/CPA-treated +ir*-CMCM 0.001
This increase in incubation period, without a concomitant
increase in variability, was the result of just two drug injections
in adult mice given about one week before sorapie. Taken with
the results of the standard PA/Tween 20 treatment it suggests that
there is a particular population of cells in the mouse, required for
sorapie pathogenesis, which is destroyed by large doses of PA and
whose replacement can be arrested by either a further course of PA
injections or a single injeotion of an alkylating agent.
An attempt has been made to increase the above effect by
adding a normal PA maintenance course to it. However, all the mice
in the experiment died within two months of a wasting disease
presumably due to excessive damage to lymphoidal tissues (Pierpaoli
& Sorkin, 1972).
Ex. 4.13 An attempt to increase the effect of PA on the incubation
period of 79A agent in VL mice by the addition of
peritoneal cell provocation
One of the possible mechanisms of the PA-effect is to cause
the immobilization of peritoneal macrophages, together with the scrapie
inoculum, in the peritoneal cavity, thus effectively delaying the
access by the agent to its replication sites in the lymphoreticular
organs. Because glucocorticosteroids both immobilise phagocytes and
severely reduce the numbers of circulating lymphocytes the barrier to
agent transport by either or both of these types of leucocytes could
be effective for several days (Thompson & van Furth, 1970). Such a
delay may also permit time for the oomplete destruction of the agent by
the phagocytes or other means of disposal discussed in SECTION 3.
Analogies for these types of relation between leucocyte and antigen
abound in the immunological literature (see SECTION 1+ DISCUSSION),
If this moael represents at least a part of the PA-effect
(and one cannot exclude direct action by the steroid on the cells which
support agent replication) then the prolongation of incubation periods
could possibly be augmented if the number of peritoneal macrophages
was increased by conventional provocation methods.
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Adult VL mioe were injected 6 days before scrapie with 3 ol.
of sterile thioglycollate (TG) medium i.p. in order to increase the
numbers of peritoneal macrophages (Argyris, 1968). Two days later
(i.e. 4 days before scrapie) they received a s.c. dose of 250 mg/kg PA
in Tween 20/saline. Three control groups received treatments as
follows: PA only (no TG); Tween 20 vehicle only (no TG); and no
pretreatment. All mice were injected at the same time with a
standard 79A supernate i.p. The PA-treated mice then received a
maintenance course of 12 s.c. injections of PA (25 mg/kg in Tween
20/saline) between 1 and 29 days after the scrapie injection.
Incubation periods were as follows:
Table 4.16
p
Group Incubation (Qf difference from
per:L0 Tween 20 controls)
Untreated controls females _
males +ioCM 2
Tween 20 controls females 197 ± 4
males 206 ± 3
PA-treated controls females 221 ± 4 <0.01
males 236 ± 5 <0.001
TG + PA treated
(Two male cases only at 215 & 260 days;
2 female and 1 male survivors at more than 400
days and*7 very early deaths)
* All 7 died with kidney damage, 35 to 102 days after scrapie injection.
(On the basis of a repeat experiment at present in progress
it has been shown that the kidney condition is caused by the drug
treatment and not scrapie). Despite the loss of numbers in the
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TG + PA group, however, the occurrence of three survivors beyond
400 days after injection supports the expectation that there is a
synergistic effect between the two drug effects.
Also of interest is the 25 day longer incubation period in
the PA controls than in the Tween 20 controls (sexes combined;
P = <0.001). A tentative conclusion, because these results are so
similar to the ones obtained in Ex. 4.12, is that the single CPA
injection in that experiment was the equivalent of the 12 x 25 mg/kg
maintenance injections of PA in this one. These PA control
incubation periods also provide a good instance of the PA effect with
79A uncomplicated by age and oil effects. They are comparable to
the results obtained in Ex. 4.10 with the ME7 and 22C agents in VL
mice.
PILOT EXPERIMENTS WITH TWO OTHER DRUGS KNOWN TO AFFECT THE LYMPHORETICULAR
SYSTEM
The effects upon the incubation periods of peripherally
injected scrapie agents of factors like the age of the host, treatments
with prednisone acetate, cyclophosphamide, araohis oil and
thioglycollate, all seem to point to explanations in terms of natural
or artificial upsets in the functions of the lymphoretioular system.
In consequence, two other drugs known to influence lymphoretioular
function have been tested at the pilot level; phytohaemagglutinin (PHA)
and 6-hydroxydopamine.
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Phytohaemagglutinin This is one of many plant lectins (Sharon &
Lis, 1972) some of which have marked stimulatory effects upon various
classes of leuoocytes (Astaldi & Airo, ^^6^) t resulting also in
splenomegaly due to increase in white pulp (Gamble, 1966). The
effects of the drug on immunological responses seem to be dependent
upon the route of administration (Petrapyi et. al., 1968) and these
differences are perhaps resolvable in terms of work by Elves (1967)
in which he showed that doses of PHA prior to antigen suppress
immune responses while ones given afterwards enhance them. He
suggested that prior treatments siphon off relevant cells or limited
metabolites.
The two pilot experiments to follow are part of a wider
project in this laboratory and their tentative observations are
supported by the results obtained by my colleagues to whom I am
grateful for their permission to quote them here.
Ex. 4.14 The effect of oral doses of PHA on the incubation period of
oral doses of 79A scrapie
Not much use has been made in this thesis of the oral route
of infection. Previous experience with the ME7 agent shows that
-2
mice injected orally with standard 10 supernates show longer
incubation periods than the same dose by the i.p. route but with
nearly 100/S incidences of disease. The intention in the following
experiment was to try to simulate in the mouse what might possibly
be a natural route of infection for slow-viral agents in sheep, mink
and humans. A recent suggestion (Asquith, et. al., 1970) that a
mitogen detected in samples of milk-derived lactoglobulin could have
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an ultimate plant origin prompted the inclusion of oral FHA treat¬
ment in this experiment,
31 male and female BitVR mice were dosed orally (using a
1 ml, syringe with the needle protected by a short length of flexible
. -3
tubing) with either a 0,04 nl, dose of 10 standard 79A supernate,
or with 0,04 ml, volumes of a mixture of 79A supernate and a PHA
suspension in 199 medium. The concentrations of agent were adjusted
to give the same dose. The PHA (Burroughs Wellcome Reagent Grade)
was b. ^Of^ suspension in 199 medium absorbed with C57 erythrocytes to
remove the haemagglutinating activity. Of the 23 control animals,
only 2 developed scrapie which was an unexpectedly low incidence on
the basis of }.!E7 experience and illustrates the consequence of
transferring assumptions regarding one agent to another. Out of the
8 animals which received FHA + 79A, however, there were 4 cases.
These are small numbers but they suggest that, at least in the case of
limiting doses of scrapie, stimulation of the lymphoreticular system
with FHA may increase susceptibility.
Gertner et, al., (1969) have shown that when ohronio
PHA-treatments are added to immunosuppressive treatments with
axothioprine and prednisone in skin allograft experiments in dogs
that there is a marked synergism. Therefore an experiment was
performed in which PHA treatments were added to a PA (in araohis oil)
regime. The PHA injections were given on five days between the
scrapie injection and the first of the follow-up doses of PA, The
agent was standard 79A supernate i.p. in VL male mice. There were
no synergistic effects, but the araohis oil and PHA-only control




Incubation P of difference
period from saline controls
Saline controls 197 i 0
Arachis oil (controls) 206 ± 2 0.01
FHA-only (oontrols) 188 ± 1 0.001
These results are also evidence for FHA encouraging the incubation of
scrapie. Because of their direct relevance to the substance of this
SECTION and in view of the paucity of these FHA results, permission
to quote the following results from an, as yet, unfinished i.p.
titration of the ME7 agent in C3H mice was given by Dr. A.G. Dickinson.
The diluent used in this titration was either saline or ^HA in saline
and the following table shows the incidence of sorapie in the various
titration groups by 360 days after injection:-
















The 100$ incidence in the 10 ^ group treated with FHA as
compared with 11$ in the saline oontrols supports the effects described
in my experiments above. Whether the results will finally show merely
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a shortening of incubation period or an increase of effective titre
remains to be seen.
In another experiment by Dr. Dickinson a 10~1 oral dose of
ME7 in MLB mice was preoeded 4 days earlier by a single i.p. injection
of PHA, and 3 hrs. before with a single oral dose of FHA. The
incubation periods of the controls and PHA-treated animals were
304 i 9 and 336 ±15 respectively - the latter group including a
single early oase of 253 days and two survivors of more than 500 days.
This is possibly an example of prolonged incubation periods resulting
from a prior treatment with PHA.
These results therefore all suggest that FHA-stimulation
can profoundly influence the course of scrapie pathogenesis and that
whether it encourages or discourages the disease could depend very
much on the relative timing of the treatment with respect to infection.
6-Hydroxydopamine (60HDA)
The second drug to be tested at the pilot level is
6-hydroxydopamine, When given neonatally this substance causes a
drastio 1 sympathectomy* and general permanent reduction in the levels
of nor-epinephrine and dopamine in several tissues, including the
brain (Angeletti, 1971). It has also been reported to upset cellular
immune responses so that treated animals will accept skin homografts
when adult (Stern, 1971).
Kx, 4.15 Two litters of VL mice were randomised to exclude any
litter-bias. One litter was given four i.p. injections of 60HDA
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(l5QMg/g) in 0.02 ml. 2^ asoorbio acid in saline on days 0, 2, 4 and
7 after birth. The control litter received the ascorbic acid
antioxidant injections only. On the 29th day of life all mice were







213 ± 2 (9 cases and one
'survivor* after 500+ days)
The increased mean incubation period has a chance probability
of only 10-20/a, but the 'survivor' is remarkable. As has been amply
illustrated in experiments using 79A agent in adult VL mice,
survivors at this age and after standard doses are unknown except
when large doses of steroid were given around the time of scrapie
injection. This result suggests that a more refined dose regime may
be possible using neonatal 60HDA injection which could permanently
protect mice against i.p. injeotions of scrapie. If this proves to
be the case it will have then to be discovered whether the drug is
having this effect by influencing peripheral or central systems.
A POSSIBLE PHARMACOLOGICAL EDIFICATION OF THE INCUBATION PERIOD OF
CENTRALLY (i.C.) INJECTED SCRAPIE
All the experiments so far described in this SECTION
investigated the effects of drugs upon the incubation period of scrapie
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administered by a peripheral route (i.p. or oral). The following
experiment shows an effect of Aotinomyoin D on the incubation period
of i.e.-injected scrapie.
The titre of ME7 agent after i.e. injection in C57 mice
begins to rise rapidly in the brain about 60 days later (Eklund, et,
al.f 1965} Dickinson, et. al., 1969). This may, of course,
represent only the first readily detectable increase in titre, but
there is accumulating evidence of a sudden onset of numerous changes
in infected brains at this time, so it could be that agent which has
merely been accumulating at critical sites within the brain up until
60 days suddenly begins to replicate with a consequent upset of normal
function. If there is such a critical period then it oould possibly
be affeoted by injections of substances known to interfere with
nucleic acid metabolism, even if only because of an impairement of
host functions on which replication might depend. An increase in
DNA metabolism has been demonstrated in mouse brains starting about
50 days after an i.e. injection of the "Chandler agent" (Kimberlin,
1972).
Ex, 4.15 Experiment to test the effect of injections of
6-meroaptopurine (6MP) and aotinomyoin D (AMD) on the
incubation period of i.e. injeoted 79A
23 A2G mice (5-7 weeks old) were injected with a standard
79A supernate i.e. 10 of these were controls and were given no
further treatment. Prom the 49th-8lst days after the i.e. injeotion
two kinds of drug treatments were given to experimental groups.
8 A2G mice received daily i.p. injections of 0.2 or 0.4 mg/mouse 6MP
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(freshly prepared every 3 days in 0.1 N NaOH and kept in the dark) from
day 49-81.
Another 5 mice were given 2 juf/mouse doses i.p. of AMD using
the following regime:
1st week: 7 daily doses;
2nd week; no injections;
3rd week: 6 daily injections;
4th week: no injections;
5th week: 3 doses.
This timing of the doses was determined by observation of
the daily fluctuations of body weight. Pour out of the five mice in
this group showed such drastic reductions in body weight during the
5th week that they would probably have died if uninterrupted treat¬
ment had continued.
Incubation periods were as follows:
Table 4.19
Group Incubation period P
Controls (untreated) 167 ± 2
6MP (0.2-0.4 mg/mouse/day) 168+2 >0.1
AMD 181+3 0.01-0.001
6MP is a base analogue known to interfere with nucleio
acid synthesis, but injections of it do not appear to affect scrapie
incubation periods (See also Table 4.1)•
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AMD, on the other hand, appears to have increased the
incubation period of this i.e. injected agent by a significant amount
although it did not have any effeot at roughly comparable dosage after
an i.p. injection (Table 4.1)• It is worth noting here that the
appearanoe of vacuolar lesions and the onset of drinking and feeding
changes in A2G mice after i.o. injections of ME7 all occur during the
period of treatment which was used in this experiment (SECTION 6 and
APPENDIX 4).
SECTION 4; DISCUSSION; THE PHARMACOLOGICAL MODIFICATION OF THE
INCUBATION PERIODS OF SCRAPE: AGENTS
Although most of this seotion has been devoted to a
description of various more or less successful attempts to modify
incubation periods these must not be allowed to obscure the fact that
the most obvious feature of all attempts to do this is their great
difficulty. In fact no successful pharmacological modification of
scrapie incubation periods has previously been published. Most other
successful methods have changed incubation periods at the cost of some
obvious damage to the host. Measures such as surgioal and genetioal
splenectomy (Fraser & Dickinson, 1970; Dickinson & Fraser, 1972)
seem to have worked by depriving the agent of at least some of the
sites of peripheral replication. It is, of course possible, that
the PA-effect is also a kind of temporary 'chemical splenectomy' and
so comes under this category, as may also be the case with AMD. But
a direot attempt to induce chemical splenectomy with ethyl palmitate
did not influence incubation periods (Fraser, pers. oomm.).
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The difficulty experienced in changing scrapie incubation
periods using pharmacological means may simply be due to a failure to
find the appropriate drug, but perhaps, in view of what we already
know about this agent, it is more likely to be because the agent's
replication is so olosely bound up with some basic host function that
it can only be affeoted by treatments which will also harm the host.
The very regularity of the incubation period of these agents, whioh
it is our intention to upset, is itself an indication that they are
probably intimately involved with some homeostatioally controlled
process of the mouse.
The only methods of significantly ohanging scrapie
incubation periods without surgical damage to the host that have
been published so far are those reported by Dickinson, Fraser, Meikle
and Outram (1972) in whioh a prior injeotion of an agent with a
•long' inoubation period in a particular genotype of host prolongs
the incubation period of a subsequently injected 'short* inoubation
period agent. The most probable mechanism for this effect is
considered to be one of site-competition. This is rather a case of
setting a thief to oatch a thief, and it may be that in the last
analysis only very sorapie-like molecules will be able to produce
fairly specifio rather than crudely non-speoific interference with
scrapie replication and do so without also damaging the host in some
way. It has often been suggested (e.g. Gardiner & Marucci, 19^9)
that the lack of immunogenicity of sorapie agents may be due to
their resemblance to some host antigens, and it could be that there
are normal replicating molecules which function in host control
mechanisms, with which scrapie agents are somehow able to compete
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(See Final Discussion SECTION 7).
Another feature of nearly all these successful treatments
is that they generally increase incubation periods. The only way of
shortening incubation periods for which there is any experimental
evidence, is the use of FHA after low effective titres of agent.
Prednisone acetate
The pharmaoological treatment whioh has been explored the
most in this thesis is that of massive doses of prednisone acetate,
s.c. during the period immediately before and after an i.p. injection
of scrapie agents. PA is an artificial steroid with enhanoed
glucocorticoid and reduoed mineralocortiooid effeots which was
developed specifically for ohronic administration where its
anti-inflammatory effeots were required without the sodium-retaining
effects whioh are inevitably present with the natural cortisone.
An examination of the gross effects of single doses of
500 mg/kg s.c. in adult VL mice of various ages is reported in
APPENDIX 2, where it is shown that all the expeoted effects of
corticosteroid treatment on lymphoreticular organ weight and
differential leuoocyte counts were produoed. Not only is there a
dramatic reduction in organ weights but there is a marked change in
differential leuoocyte count including reduoed proportions and
absolute numbers of small lymphocytes and elevated numbers of
polymorphonucleocytes.
It is generally considered that PA has about 3 times the
glucocorticoid effeot of cortisone acetate, so the effeotive levels
used on adults in these scrapie experiments greatly exceeds that
generally used in experimental work. It is remarkable therefore that
apart from a slight reduction in body weight during the period of
treatment, the mice seem to remain quite healthy and to return to
normal body weights soon after the last injeotion. Only when the
drug was given to very young mice, or in a regime that also inoluded
other drug treatments like cyclophosphamide or thioglycollate have
there been instances of persistent low weight, kidney-failure, and
wasting disease.
The chief features of the PA-effeet upon scrapie incubation
periods are as follows:
- prolonged inoubation periods are obtained, especially when
high initial doses are used and there is at least three weeks
maintenance treatment starting soon after the scrapie injection;
it is easier to produce this effect in very young than in
older mioe, in the sense that lower and fewer doses are needed.
The most effective point appears to be when the scrapie is given
between one and two weeks after birth;
it is not yet possible, however, to distinguish the
contributions to this effect of age of host, PA- and araohis oil-
treatments;
PA injections given in early life do not have a permanent
affeot on the host's susceptibility to scrapie;
- some kinds of regimes, e.g. single injections of PA within
the fir3t few days of life, and perhaps spaced treatments later, may
conduce to a shortening of incubation period, perhaps by produoing an
increase in the acrapie-supportive tissues due to a rebound phenomenon.
These observations are not yet complete enough to more than
indicate possible reasons for the PA-effect. Steroids influence so
many aspects of the physiology of mammals that it is possible to
suggest many models that are compatible with the data, and do so with
the lurking suspicion that the relevant effect may be beyond the
frontiers of present knowledge. However, from what is known of the
association of scrapie with the lymphoreticular system, and of the
effects of spleneotonQr and of hereditarily spleenless mice in
increasing scrapie incubation periods, it is very likely that the cause
of the steroid-effect is to be found somewhere in its well-known
capacity for lymphoretioular depression. This discussion will
therefore continue on this assumption and some other possibilities
will be reserved for the final discussion in SECTION 7.
High doses of steroids (at least in rodents) have marked
immunosuppressive effects both on the humoural and cellular fronts
(Berglund, 1956, 1962; Kass, 1960; Cohen & Claman, 1971)• These
are perhaps due to the accompanying great reduction in circulating
lymphocytes, (which is partly the result of lysis and partly to
sequestration in unknown sites) and to the reduction of lymphoid
areas in the spleen, lymph-nodes and thymus (ishidate & Metoalf, 1963;
Elliott & Sinclair, 1968; Cohen, Fischbaoh & Claman, 1970). Also
of interest is the anti-inflammatory effect of maryr steroids which
has been variously attributed to the stabilisation of lysosomal
membranes (Bunim, 1959; Symons, et. al., 1969) and the immobilization
of phagocytes in whatever tissue they happen to be found at the time
- 92 -
of treatment (Thompson & van Furth, 1970). Of particular note here,
especially in view of the negative results in scrapie experiments
reported from the use singly of drugs like cyclophosphamide,
6-mercaptopurine and aotinomycin D (Table 4.1 and Worthington &
Clark, 1971), is the demonstration that there are populations of
cells in lymphoid tissues that show resistance to lysis by some of
these substances but not to others (Miller & Cole, 1967). Evidence
for a * steroid-resistant' population of cells in the medullary cords
of the thymus which i3 fully capable of mounting a graft-versus-host
reaction has been put forward by Blomgren & Anderson (1969) and Cohen,
Fischbaoh & Claman (1970). Similar populations of steroid-resistant
cells, probably of thymic origin, have also been found in the spleen
(Cohen, et. al., 1970) and in the bone-marrow (Levine & Claman, 1970)
but these may have 'taken refuge' there as a result of the steroid
treatment (Moorhead & Claman, 1972). It is likely that suoh cells,
being members of the lymphoid population would suocumb to steroid
treatment at even higher doses suoh as the PA doses used in this
thesis, and if so, these could include the sorapie-supportive cells
that have been suggested on the basis of the neonatal age-effect
(SECTION 3).
Of interest too, in view of the tentative results obtained
with FHA is the fact that these steroid-resistant cells, in common
with other 0-bearing cells are the bulk of the FHA-stimulable
population of lymphoid tissues.
Another suggestive demonstration, by Nettesheim & Hammons
(1970), showed that treatment of mioe by several immunosuppressives
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including 500 mg/kg of cortisone acetate interfered with antigen
retention by the spleen ( I human IgG-). A similar failing
could ultimately lie behind the finding (Ex. 4.2) of no scrapie agent
in the spleen of a PA-treated survivor. These authors, however, also
found this failure of antigen retention after 400r X-ray,
actinomyoin D (0.9 mg/kg), cyclophosphamide (300 mg/kg) (all single
injections i.p. in saline). This suggests that even these treat¬
ments could be successful in modifying scrapie pathogenesis provided
a sufficient dose rate could be found and maintained. On the other
hand they may fail even at high dose due to the lack of some other
anoillary effect like macrophage immobilisation which is possessed
by the steroid.
Thompson & van Furth (1970) have investigated the
effects of gluoooortioosteroids on the kinetics of mononuclear
phagocytes in adult Swiss mice. They showed that single large doses
(in the region of 750 mg/kg of hydrocortisone) reduced circulating
monocytes for up to 2 weeks (probably by sequestration in an unknown
site) and kept the numbers of peritoneal macrophages unchanged
(probably by immobilization). They also found a great reduction of
the numbers of circulating and peritoneal lymphocytes but a rise
after a few day3 in the numbers of polymorphonuoleooytes (of.
APPENDIX 2). This result suggests the possibility that the
PA-treatment of mice with scrapie may cause the trapping of the
homogenate in the peritoneum with immobilised macrophages long enough
for the activity of the agent to be reduoed or destroyed. This
assumes that these steroid-immobilised macrophages are still fully
capable of enzymio degradation but this may not be so. Although
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there is evidence that steroids do in fact impair these types of
functions, perhaps by stabilizing lysosomal membranes (Symons, et. al.,
1969; Weissmann, 1967J Ignarro & Colombo, 1972) there are some
conflicting findings (Hirsch & Churoh, 1961} Allison & Adcock, 19^5;
Alexander et. al., 1968). Recently Chandra & Seth (1972) reported
enhanoed intracellular killing of Staphylococcus aureus by
polymorphonucleocytes from patients receiving, prednisolone treatment
for a nephrotic syndrome. The effect of PA-treatments on the ability
of macrophages to digest bacteria, brain homogenates and other organic
materials has not yet been investigated.
Arachis oil
The possibility that phagocytic aotivity may be important in
the peripheral pathogenesis of scrapie is also suggested by the effeot,
discovered by acoident, of arachis oil in prolonging incubation periods
in experiments where it was used as a vehicle for steroids. The
effect is known to ooour with 79A in VL and A2G mice, and 22A in VM
mice. A preliminary investigation has been made on the effeot upon
peritoneal cells of VL mice of 0.1 ml. araohis oil i.p. Peritoneal
washouts with heparinized saline were examined daily for one week
after the i.p. injeotion. The total cell-count was increased ten
times within 24 hrs. of the injection and then slowly returned to
normal during the week. No attempt was made to differentiate between
oell types, which were in any case in such an activated state that
identification would probably have been doubtful. For three days
after the injeotion many oil droplets were surrounded by clusters of
large oells (probably macrophages) and numerous granulated cells
- 95 -
containing oil droplets were observed. Within a few minutes of
placing the samples on the counting chamber,cells began to adhere to
the glas3 and commence spreading. This seemed to apply even to the
smallest round oells, tentatively identified with small lymphooytes.
These observations prompted a search in the literature, and two
isolated observations of possible relevance have so far been found.
Boyd et. al., (1959) reported that extracts of Araohis hypogaea
contained a lectin that showed weak agglutinating properties with
some human blood samples. The erythrocyte antigen was not
identifiable with any known blood group antigen and was tentatively
assigned the designation 'Gy*. Sugar-competition experiments
suggested that the receptor had a galaotose-glucose termination.
Previous to this, Long & Martin (1956), investigating the claims for
an antirheumatic activity of a particular drug, found this activity to
reside in the arachis oil base. Purification yielded what seemed to
be 10-14 carbon amine attached to phospholipids which had about 10^
times the desensitizing ability of cortisone acetate when tested on
the tuberculin reaction in guinea-pigs sensitised to B.C.fr.
Curiously, neither of these observations seems to have been pursued
aiy further. While either or both of them could be relevant to the
effect of arachis oil on scrapie incubation periods it is not possible
to say what meohanism is involved. A prolonging of incubation
periods of i.p. injected agents could, however, be produced by
diametrically opposite effects namely, by 'blockade' or enhanced
phagocytosis. While 'blockade' would suspend any phagocytic activities
it could result in a mere postponement of the pathogenetic process.
Alternatively, the stimulation of phagocytosis and digestion could
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result in an effective reduction in titre and hence increased
incubation periods. These alternatives could be examined in a
preliminary way using conventional substrates to measure phagocytic
activity. There is also some evidence for a synergism between PA
treatment and the prior injection of the macrophage stimulant,
thioglycollate (Ex. 4.13). Macrophages could, however, ploy a more
positive role in the pathogenesis of scrapie than the above
suggestions have implied, and it is possible to demonstrate some
suggestive parallels between the role of macrophages in immune responses
and those postulated for scrapie pathogenesis. Fundamental
immunological research has shown that maorophage-processing of
antigen is often essential for a proper immune response (especially
with particulate antigens) ( Fishman, 1961; Hulley, et. al., 1964;
Hosier, 1967; Pierce & Benacerraf, 1969). Such processing also
seems to enhance their immunogenieity (Mitchison, 1969)» although
whether this is due to a mere 'cleaning-up' process or to an
adjuvant-like association of the antigen with a BNA moiety, or even to
the production of some specific 'informational RNA* which then
directs the immune response, has not yet been settled (Fishman &
Adler, 1963, 1968; Fishman, et. al., 1963; Adler, et. al., 1960;
Pribnow & Silverman, 1967; Bishop, et. al., 1967; Gottlieb &
Straus, 1969; Fishman, 1970). Linked with this kind of work are
the observations of physical associations between macrophages
containing antigen and lymphocytes, with the formation of temporary
uropods (McFarland, et. al., 1966) and maorophage-lymphocyte 'islands*
(Pieroe & Benaoerraf, 1969; Bona, et. al., 1972). The effects of
prolonged exposure of antigen to macrophages are relevant in this
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context too. Although in such ciroumstances most of the antigen
is quickly digested, a part of it can be retained for longer periods
in the phagolysosomes (Unanue & Askonas, 1968a, 1968b; Kolsoh &
J'itohison, 1968) and on the surface of the oell (Unanue, et. &l., 19^9)•
However, very prolonged exposure of antigen to macrophages, espeoially
when these have been stimulated, can result in reduced antibody
production in experimental systems (Jennings & Oates, 1967;
Perkins & Mackinnodan, 1965; Ehreneich & Cohn, 1969). Finally,
while antigen in splenic lysosomes may retain its antigenicity for
some time, this may be lost quickly in hepatic Kupffer oells
(Franzl, 1962) and the titre of scrapie agent is reportedly low in
liver (Eklund, et. al., 1967). All these kinds of immunological
observations are subject to numerous operational qualifications
regarding exact regimes, antigens, host strains, modes of administrations
etc. which while they are the bane of the immunologist, they do
provide scrapie workers with some suggestive models.
Clearly all these possibilities of •conversations* between
different members of the lympho-retioular population involving as
they do the passing of residual materials, could provide an ideal
mechanism for the transport and even the replication of certain
infectious agents, although there is no direct experimental evidence
for anything of the sort with scrapie.
A tentative model
The following is sin attempt to hold together the separate
effeots on incubation period due to age, PA and arachis oil.
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(a) i.p. injeoted scrapie supernates are first ingested by
peritoneal phagocytes including macrophages. Much of the non-
scrapie material and perhaps some of the agent is digested and the
products excreted in the normal manner. Some of the scrapie agent
(associated or not with some donor-tissue component; see SECTION 5)
survives to be passed to peritoneal lymphocytes or be oarried into
the circulation while still in, or on, the macrophages (peritoneal
macrophage turn-over in Swiss mice is about 2jj0 days: Thompson &
van Furth, 1970). The titre of agent that emerges from this phase
(and the timing of the emergence) will depend upon factors like:
the maturity of the phagocytes (i.e. their ability both to ingest
and then digest organio materials, which is a function of the
individual's age), the degree of activity of the macrophages (whether
or not stimulated by substances like mineral oils, glyoogen,
allogeneic serum, thioglycollate, or blockaded by cholesterol, carbon,
silica etc.), and the mobility of macrophages and lymphocytes
(whether or not immobilised or lysed or just subdued by steroid
injections).
(b) these macrophage-processed agents (or donor-agent complexes,
SECTION 5) are then transported to the replication sites which
probably occur somewhere in the tissues of the lymphoreticular
system. This transportation could be done by macrophages in
circulation as monocytes, or by lymphocytes to which the agent has
been passed by macrophages in a manner similar to that for antigens
and BNA-antigen complexes.
This phase of pathogenesis could be upset by treatments
which either lyse or cause the sequestration of the transporting cells
such as would be the action of PA on both small lymphocytes and
monocytes.
(o) on arrival at the peripheral target sites whioh are capable
of supporting the replication of the agent, some at least of the
agent particles may be passed onto these cells whioh could be plasma
cells or the lymphocytes of the cellular immune system. Agent in
excess of site-number oould perhaps be taken up by other elements
like reticular cells whioh are thought by some to function as an
antigen reserve for the maintenance of immunological memory. Or these
cells could be themselves the site of agent replication.
Accumulation of agent at these target sites oould obviously
be prevented by faotors like: complete absence due to maturational
defioienoy of transporting and/or receptor cells, or the inaotivation
or depletion of the relevant cells by drugs like PA at high dose.
Finally as an alternative or supplementary consideration,
it may be noted that there is evidence that treatment with
corticosteroids can prolong the life of laboratory animals (Friedman,
et. al., 19^5; Bellany, 1968)• It has often been suggested that
some aspects of the pathology of scrapie resemble premature ageing.
If scrapie produces something like a hastened ageing of a particular
brain-cell population then the PA-treatment may prevent this ooourring
so rapidly. Other possible models will be disoussed in SECTION 7.
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Phytohaemagglutinin
My results reported in this SECTION with this drug must be
regarded as tentative although they are supported by other evidence
from the unit. In view of the possible light whioh these oould throw
on the PA- and neonatal age-effeots it is worth discussing them
briefly at this point.
FHA appears to stimulate the 0-bearing, thymus-derived
lymphocytes, causing them to enter biastogenesis. In this state they
have greatly enhanced capacities for supporting some viral infeotions
in vitro (Herpes simplex: Nahmias, et. al., 1964; vesiouiar
stomatitis: Edelman & Wheelock, 1966; mumps: Due-Nguyen & Henle,
1966; .vaccinia: Miller & Enders, 1968; yellow-fever: Wheelock &
Edelman, 1969). Morphologically, FHA-treated mioe show a splenomegaly
with greatly increased quantities of white-pulp (G-amble, 1966). The
effects of PHA stimulation on immunological responses are somewhat
contradictory in the literature, apparently depending on route of
injection (Petraryi, et. al., 1968). Such results are perhaps
resolvable in terms of an experiment by Elves (1967) in which he
showed that the antibody response of rats to chicken red blood cells
was suppressed by prior doses of FHA but unaffeotea or enhanced
by subsequent ones. He suggested that prior treatment 'siphoned off*
some cells whioh were relevant to the immune response.
These observations, taken with the results of the scrapie
experiments using PHA, suggest that there may be a PHA-sensitive
population of oells that is of central importance in scrapie
replication. This could, indeed be the relatively steroid-resistant
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group postulated earlier, which could nevertheless succumb to very
high, persistent doses. Prior treatment with FHA could pre-empt
these cells or some necessary physiological process so that they
were no longer available for scrapie replication and so allowing
the scrapie deactivation mechanisms full reign for a time and thus
increasing incubation periods, or on the other hand, simultaneous
or subsequent FHA treatments (with respect to scrapie infection)
may stimulate cells that are already infeoted, which could hasten
the replication of the contained agent. This would shorten
incubation periods of those doses of agent which do not already
exceed the number to saturate available replication sites i.e. low
titres. Hastened agent replication could be due in stimulated
oells to either a generally more metabolioally active environment
or specifically to more rapid turnover of DNA which would accord
with the suggestion that agent replication in tissue-culture is in
ooncert with cell-division (Clarke & Haig, 1970).
If the postulated, limited number of sites (or cells)
capable of supporting scrapie replication is a thymus derived,
relatively steroid-resistant, FHA-stimulable one, then this may
account for another slightly anomalous scrapie observation: that
although the titre of agent after s.o. injections rises quickly in
the 3pleen and lymph nodes, a rise in titre in the thymus is not
detected until two months later - about the same time as the
salivaiy gland. Of course, there are no germinal centres in the
thymus and so on an analogy with antigen one would not expect agent
to appear in this gland. However, it is very rioh in lymphocytes,
so it is possible that the infeoted lymphocytes in the gland are
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simply a very small minority of the total population, suoh as the
steroid-resistant cells. A similar explanation for the salivary
gland would point to the small proportion of oells that are concerned
with IgA production whioh are presumably the most likely candidates
for the sites of scrapie infection. Another lymphoid organ whioh
shows low agent titre is the ileum. Again the question of
proportion of cells arises sinoe the Peyer's patches are only a part
of this organ, but it should be noted that 6-bearing oells seem to be
absent from the lymphocytes of this tissue whioh is one reason for
regarding it as the Bursa of Fabrioias-equivalent in mammals and
therefore composed entirely of B-oells (Heim, et. al., 1972).
However, these speculations regarding a possible role for
T-oells (or at any rate @-bearing cells) in scrapie pathogenesis
have to be seen in the light of the demonstration by McFarlin, et. al.,
(1972) that adult thymectomy followed by irradiation and reconstitution
with foetal liver oells did not signifioantly influence the incubation
period of peripherally injected scrapie (although it was profound
enough to cause a permanent loss of the ability to reject skin
allografts and the complete disappearance of detectable 0-bearing
lymphocytes in the spleen). However, this result does not
necessarily discount the possibility of the kind of model I have
proposed since the particular population of T-oells needed for scrapie
replication may be widely dispersed in the adult mouse and also
radiation-resistant, or alternatively, it (unlike the cells needed
for allograft rejeotion) may have precursors in foetal liver cells.
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6-hydroxydopamine
The result with this drug are even more preliminary than
those with PHA so they will be discussed very briefly. 60HDA causes
a profound depression of catecholamine levels in several organs of the
body, including the brain (Uretaky & Siaraonds, 1971 )• Given
neonatally it oauaes a permanent •ohemioal sympathectomy' (Angeletti,
1971) and permits treated mice to accept skin allografts in adulthood
(Stem, 1971)* The effects on cateoholamine levels are perhaps oore
relevant to the disoussion of the ohanges in behaviour with scrapie
which are dealt with in SECTION 6. The effect on cellular immune
responses appears not yet to have any known basis. Oevoino and
Teliseyeva (1971) have shown that another biogenic amine,
5-hydroxytryptamine, is involved in the immune response. Neonatal
injections of epinephrine, especially when given with prop iomaline
HC1 impairs both huaoural and cellular immune responses in rabbits
when adult (Henson, Ball & Brunson, 1968; Henson & Brunson, 1969)*
These results suggest that 60HDA could also have direct effects on
some oells of the immune system which may also be those required for
scrapie pathogenesis.
Aotinomyoin D
With these results we pass to an entirely different aspeot
of sorapie pathogenesis. The AMD-effeat was produced with i.e.
injected scrapie. Reasons have been given in SECTION 1 for
supposing that i.o. injected agents proceed to replioate in situ thus
omitting several pathogenio stages which they would have been
obliged to perform had they been injected by a peripheral route.
104 -
Kimberlin & Anger (1969) and Kimberlin & Hunter (1967) have demonstrated
a brief period of ^H-tbymidine incorporation by sub-ependymal cells
during the period immediately after an i.e. injection. Perhaps
these are the first cells to be affected by the agent which show an
immediate, transitory response in terms of DNA turnover which does
not become widespread in the brain until several weeks later when
another phase of DNA turnover begins (Kimberlin, 1972). Perhaps
this occurs when the level of agent crosses the threshold for making
this response in other parts of the brain as a result of accumulation
and replication. This phase also inoludes the appearance of numerous
other signs of malfunctions subtle behavioural changes (SECTION 6),
vacuolation of neurones, astrocyte hypertrophy, rise in levels of
some brain glyoosidases, inoreased acetylation of histones (reviewed
by Kimberlin, 1973) and a sharp decline in spermine levels (spermidine
levels unchanged) (Shaw, pers. oomm.). These changes constitute a
great stepping up of activity which could represent the crossing of
some metabolic threshold such that homeostasis can only be maintained
by greater aotivity. AMD, which causes a breakdown of normal DNA
metabolism (e.g. Wells, 1969} Brachet & Hulin, 1969) and is widely
used for stopping the production of proteins (e.g. Honigg & Rabinovitz,
1965} Pastan & Friedman, 1968) could postpone sorapie incubation
periods if injected at this critical point in pathogenesis, especially
if scrapie replication requires normal host responses suoh as
transcription. Similar to the lack of effeot with 6WP is failure to
change incubation periods with 5-iododeoxyuridifte and monbhydrcocyurea
reported by Kimberlin and Hunter (1967).
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SECTION 5
EFFECTS ON THE PATHOGENESIS OF ME7 SCRAPIE WHICH MAY
BE ATTRIBUTABLE TO DONOR TISSUE COMPONENTS
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EFFECTS Y/HICH MAY BE ATTRIBUTABLE TO DONOR TISSUE COMPONENTS. GN THE
PATHOGENESIS OF PERIPHERALLY INJECTED ME7 SCRAPIE
This SECTION is an account of my own contribution to a
project in progress in these laboratories which has been designed to
investigate another possible source of variation in scrapie pathogenesis,
namely the potential effects of donor tissue components which are of
necessity present in the inooula, if not aotually complexed with the
agents. The first results of this work have been published
(Dickinson & Outram, 1973; Outram, Fraser & Y/ilson, 1973 - see
APPENDIX 6). The following aooount will therefore begin with a brief
synopsis of the project so far, and then go on to describe my own
contributions and extensions.
Summary of the design and results of the first phase of the
BALB/BRVR project
In the course of the 3tudy of variation in experimental
scrapie in mice it had been shown that the following factors were
operative in terms of modifying incubation periods and lesion profiles:
the strain of agent, the genotype of the host, the route of injection,
the tissue-source (brain or 3pleen) and sometimes the sex of the
recipient (See SECTION 2). The donor-ti3sue components which are
inevitably present in the inocula are another potential source of
variation. In order to study this possibility, however, it is
necessary to use an agent source for which there is good, widely based
evidence that it is stable in its properties and likely to be a
single strain of agent rather than a mixture of strains. The ME7
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agent meets these oriteria better than any other which ha3 been
studied in detail. At the start of this project,ME7 had already been
passaged by the i.e. or i.p. routes serially in several strains of
mice without any signs of breaking down into separate components or
of changing its properties in any other way, and in this it can be
contrasted with the majority of isolates from sheep (Dickinson, pers.
oomm), ME7 has now retained its status in these respeots during 11
years of intensive study in these laboratories. In particular, it
has been passed 11 times in C57 mice (s7s7) and 7 times in VM mice
(p7p7) and remained unohanged in its properties as indioated by
incubation periods and lesion profiles in both these genotypes
(Dickinson, 1970; Praser & Diokinson, 1973; Dickinson, pers. comm.).
For the purpose of this investigation therefore, some ME7
material from 2nd C57 pass was injected into BALB, BRVR and further
C57 mioe using both the i.e. and the i.p. routes of injection in a
Passage history of material used in BALB/BRVR experiments








* in both BALB abd BRVR recipients (See Table 5«1)
— 108 —
sequence of experiments which principally used ohanges in the P/C
ratio (ratio of i.p. to i.e. incubation periods: see SECTION 2) as
an indioator of changes in pathogenesis. In the event the passage of
ME7 in either the MLB or the BRVR mice not only resulted in a marked
difference between the two in P/C ratios but produced significant
histological differences also. These are important for the
interpretation of the causes of the modified patterns of pathogenesis.
At the present time, the discovered changes are being investigated by
passing the material back and forth between genotypes in order to
determine what proportion of the differences between the BALB and
BRVR sublines of ME7 are transitory properties due to the genotype of
each inoculum - perhaps due to only the normal tissue antigens
present.
An outline of the experimental procedures is as follows:
standard ME7 3upernates from the brains and spleens of terminally
affected individual BALB and BRVR mice were injected by either the
i.o. or the i.p. routes into weanling BALB and BRVR mice. Inoubation
periods and lesion profiles were obtained in the normal manner.
Then BALB and BRVR brain and spleen materials from this experiment
were used to inject a second set of BALB, BRVR and C57 mice by both
the i.o. and the i.p. routes. The incubation periods from both these
experiments are shown in Table 5.2. The lesion profile data was
analysed using a multivariate technique specially developed for the
purpose by Mr. D.T. Wilson and the results are illustrated in
Figs 1-4 and desoribed in full in the appended paper (Outram, Fraser &
Wilson). Meanwhile oross-titrations by the i.e. route were carried
out in BALB and BRVR mice of the BALB and BRVR materials used for the
- 109 -
first experiment, shown in the passage diagram. These showed that the
titres were essentially the same in the two sources:
Table 5.1 Estimated titres (Reed-Muenoh)




In addition both subline standard brain inocula were injected
into VM (p7p7) mice because this has proved to provide the most
sensitive indioator of agent/strain differences, but this gave no
evidence that the two sublines were different.
The results of these two experiments in terms of incubation
periods, P/C ratios and lesion profiles finally break down into 80
groups, and it is unnecessary to go into the details here. The
chief points to emerge are that the i.o. data, so far obtained, all
strongly suggest that the ME7 is essentially unchanged in its
properties after passage in these diverse hosts but that some
association with components of BRVR tissues results in changes in
peripheral pathogenesis and subsequent central pathogenesis. These
changes are expressable as a decreased neuroinvasiveness (larger P/C
ratios) and markedly different lesion profiles of the BRVR-passed ME7
after i.p. injection in both strains of recipient, which could
indicate a different pattern of agent distribution in the brain.
This latter possibility cannot be established at this time since the
relationship between lesion density and agent distribution is not known,
Table5.2IncubationperiodsforME7gentwh chh dbe
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Figure 5«5 Lesion profiles in BALE recipients of ME7 (brain)






Figure 5*4 Lesion profiles in BRVR recipients of ME7 (brain)
injected i.p. from BALB . or BRVR — donors
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but some general relationship of the two is not an unreasonable
expectation.
Multivariate analysis of the lesion profile data showed
that significant variations due to the strain of the reoipient after
i.p. injection occurred in positions 2,3,6,8 and 9, the most
significant being at 6 (hippocampus) (Outram, fra3er & Wilson, 1973).
The differences due to donor strain in individual brain positions
after the i.e. route were even more significant than those after the
i.p. route but an analysis of the change of 3hape showed that the
cause of these larger variations was largely one of level of
intensity rather than difference in shape.
If the patterns of lesion distribution refleot in some
degree the distribution of agent then it is fairly easy to envisage
simple physico-chemical causes for differential distribution of the
inoculum after an i.e. injection, according to the strain of the donor.
Presumably even normal tissue components from different genotypes
could be differently distributed. These differentials could bias
the sites where agent replication would begin. It is more diffioult,
however, to see how donor tissue components could influence lesion
profiles after a peripheral injection,especially since the agent does
not appear to gain access to the brain until several weeks after injection.
The possible meohanisms include; 3ome kind of 'priming' of the brain
by the inoculum at the time of injection which then influences the
pattern of subsequent agent damage; infection of the brain could be
at least partly by unchanged homogenate (i.e. still associated with
donor components) whether immediately or after several weeks of storage
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in some peripheral tissue; the replication of donor-tissue molecules
along with the agent in peripheral cells - (even this type of
possibility cannot be entirely dismissed); or the enlisting of host
speoific immune responses to the donor components, leading to some
incipient autoimmune reaction which results in a deposition of the
agent in corresponding target sites ('immunological aiming', see
later).
My contribution to this project
I was given the opportunity to examine the histological data
of the first set of the BALB/BRVR experiments and to 3tart some
experiments to test for the possibility that immunological mechanisms
were involved in the changed P/C ratios and lesion profiles.
Results
The analysis of the histological data led to two findings.
One (described above) was that the shape of the lesion profile in i.p.
injected animals was, visually, more obviously influenced by the
strain of the donor than by that of the recipient. This was the first
time that an effect on lesion profiles due to the strain of the donor
had been observed in these laboratories. Subsequent multivariate
analysis, however, showed that recipient effects were in fact as
significant though less obvious to the eye and to simpler forms of
analysis. (Praser, 1971; Outram, Praser & Wilson, 1973).
The second histological observation was the discovery that
a high incidence of white-matter oedema was commoner in animals
receiving BRVR-passed ME7 (brain or spleen) than in animals receiving
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BALB-passed ME7; this effect was most marked after i.p. injections.
This association of white-matter oedema with BRVR-passed ME7 is
another indication that a modified pathogenesis occurs in KE7 from
this host genotype. The percentage incidence of this lesion and \
tests of its association with donor and recipient genotypes are shown
in Tables 5.3 and 5.4.
Table 5.3




n % n %
BALB BALB 63 68 40 15
BRVR 26 35 31 29
BRVR BALB 43 70 39 90
BRVR 45 60 49 86
Table 5.4 X2 tests of the significance of the associations of the
white matter oedema incidences with the two donors and reoipients
Donors Recipients
i.e. i.p.
BALB & BRVR BaLB >0.1 <0.001
" BRVR .05-.02 <0.001
BALB BALB & BRVR .01-.001 >0.1
BRVR " >0.1 >0.1
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Ex. 5.1 An experiment to investigate the possibility that normal BRVR
brain may contain a faotor which could modify the pathogenesis
of BALB-passed ME7
38 BA1B mice were injeoted by the i.p. route with a standard
brain supernate of BALB-passed ME7 to which had been added an equal
volume of normal brain supernate taken from either a BALB or a BRVR
mouse. The objeot was to look for any changes of incubation period,
lesion profile or white-matter oedema due to the BRVR normal brain.




BALB-passed ME7 + BALB brain 257 ± 2 nil
BALB-passed ME7 + BRVR brain 258 +2 nil
The absence of significant differences in the pathogenesis
of the BaLB-passed ME7 in the two inocula in terms of incubation
period and lesion profile oounts against the possibility that the
BRVR stock contains an infectious entity which somehow influences the
peripheral pathogenesis of scrapie. It suggests instead that in
infected BRVR inocula there are components which are either absent
from normal BRVR brain or present at much higher concentrations, or
are complexed with the agent in a manner which a mere mixing of
inocula does not simulate, and that these components are responsible
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Figure 5»5 Lesion profiles of BALB passed ME7 (brain) i.p. in BALB







Figure 5»6 Lesion profiles of BALB passed ME7 (brain) i.p. in BRVR
recipients in the original BALB/BRVR experiments . 'and in
BRVR recipients pretreated with normal BALB brain i.p.
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Ex. 5.2 An experiment to investigate the effect of several
pretreatments of BALB or BRVR mice, respectively, with normal
BRVR or BALB brain homogenate. before injecting ME7 in
allogeneic brain by the i.p, route
This was another attempt to see if normal tissues contained
factors which would influence the pathogenesis of i.p. injected scrapie.
BALB and BRVR mice were given courses of their own (isogeneic) or each
other's (allogeneic) brain suspensions i.p. for several weeks before
receiving i.p. injections of allogeneic brain infected with ME7.
It was expected that such pretreatments might exaggerate the changes
in pathogenesis associated with allogeneic donors.
55 BALB and 42 BRVR mice were each divided into 5 groups as
shown in Table 5.6. The group 5s were the basic oontrols receiving
no form of pre-treatment before the i.p. injection of standard NSE7
brain supernate (0.1 ml.) in allogeneic tissue. The group 4s
constituted a second control receiving a full course of three-pretreatments
with isogeneic normal brain before receiving ME7 from the isogeneic
source. Groups 1-3 received up to 3 pretreatments i.p. with normal
allogeneic brain before the i.p. injection with standard allogeneic
ME7 brain supernate. (The ME7 materials were obtained from the first
of the original BALB/BRVR experiments so that, except for the dose of
agent, this experiment (5.2) represents the same passage status as the
second of the original BALB/BRVR experiments).
A comparison of titre in the BALB- and BRVR-passed materials
was made by i.e. injection of RIII mice. The incubation periods
were 161 ± 8 days for the BALB material and 155 i 3 days for the
BRVR, indicating almost identical titres.
The incubation period results are shown in Table 5«7 and
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BALB BRVR 1 214 + 2 —
2 216 + 2 -
3 217 + 2 -
5 217 + 3 -
BRVR 4 244 + 11 +
BRVR BALB 1 290 + 6 +
2 277 + 9 +
3 303 j- 8 +
5 279 + 9 +
BALB 4 260 + 13 mm
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The incubation periods in the control groups (4 & 5) show the same kinds
of relations to each other as the combinations in the original
experiments, except that they are about 25 days earlier probably
because of the greater volume (0.1 ml.) of inoculum used. It can be
seen that the BRVR source of ME7, although having the slightly shorter
incubation period in the RIII i.e. titre controls, showed a reduoed
neuroinvasiveness as compared with the BALB source material when
injected i.p. and it also produced the white-matter oedema that is
characteristic of BRVR-passed ME7.
The pretreatment of BRVR mice with normal BALB brain before
injections with BALB-passed ME7 had no effect on pathogenesis either
in terms of incubation periods or lesion profiles (Pig. 5.6).
However, the pretreatment of BALB mice with normal BRVR brain produced
marked changes in the mean incubation periods of the various groups,
and the lesion profiles appear to have been modified also. There are
significant variance ratios (P <.05) of group 4 compared with groups
1,2,3 & 5 in both halves of this experiment urging some caution in the
direct comparison of mean differences by t-tests. V/hen the
incubation period results are classified by sex (Table 5.8) it can be
seen that the pretreatments have marginally increased the incubation
periods of the females but not of the males. The variance ratio for
the treated and all the untreated females shows a significant change










significance of difference from
control mean
females males
BRVR BALB 3 1 305± 5 0.05-0.02 270± 8 0.1
2 2 277±14 0.1 277+ a 0.1
1 3 307±10 0.1-0.05 293± 8 0.1
0 5 283± 8 271 ±24
The original experiments showed that the change in
neuroinvasiveness in the HRVR-passage line was accompanied by significant
changes in lesion profile. This is illustrated clearly in Pigs. 5.3 & 4.
(See also Outram, Fraser & Wilson, 1973). In order to decide whether
the lesion profiles were altered as a result of the pretreatments in
Ex. 5.2 it was necessary, because of small numbers, to amalgamate the
three pretreatment groups (1,2 and 3). The contemporary control
groups were also too small to be the basis for a reliable comparison.
Instead, a comparison was made of the lesion profile for all the
BALB mice pretreated with BRVR brain in this experiment with that of
the BALB mice injected with BRVR-passed ME7 in the original experiments
(i.e. without any pre-treatments) and this shows some interesting
features (Pigs. 5.7 and 5.8). It can be seen that while pretreatment
of BRVR mice with BALB normal tissues has not changed the lesion
profile (Fig. 5.6), the pretreatment of BALB mice with BRVR normal
tissue has. In particular, the scores in positions 5, 6 and 7 are
higher than in the non-pretreated BALBs. If one oompares the













as compared with that of BALB-passed ME7 (Figs. 5.1-4), then it can be
seen that pre-treatment with BRVR normal tissue in thi3 experiment has
amplified some of these differences (See Fig. 5.8). A Lawley-Hotelling
multivariate t-te3t was used to estimate the significance of this
amplifying trend, and it was found to have a chance likelihood of
only 1?S. It is concluded that the pretreatment of BALB mioe with
normal BRVR brain material prior to injections of BRVR-passed ME7 has
tended to decrease neuroinvasiveness still further and to exaggerate
the ohanges in lesion profile shape.
SECTION 5 DISCUSSION; TBS ROLE OF DONOR-TISSUE COMPONENTS IN ITS
PATHOGENESIS OF PERIPHERALLY INJECTED SCRAPIE
This subject is under active investigation in these
laboratories at the present time and the data presented in this section
can do no more than indicate that an effect of donor tissue components
has been established in the case of one particular agent/host strain
combination and to go some way towards suggesting possible ways in
which they could be operating.
The general significance of the original BALB/BRVR experiments
have already been discussed earlier in this SECTION, so it remains to
consider in what ways the results of the two experiments reported in
Ex. 5.1 &nd 5.2 can add to our understanding. They indicate that
while the administration of normal BRVR brain material at the same time
as an injection of BALB-passed MK7 i.p. in BALB mice has no effect on
pathogenesis (Ex. 5.1), the pretreatment of BALB mice with normal BRVR
brain two weeks or more prior to an injection of BRVR-passed ME7 does
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influence pathogenesis (Ex. 5.2). The form which this influence
takes is to increase the variance of the incubation periods with a
slight increase of the mean and to continue further the trends in the
changes of lesion profile shape which BRVR-passed ME7 shows compared
with BALB-passed ME7. Additional experiments to check and extend
these findings are in progress.
The effect of the BRVR tissue may be due to some generalised
stimulation of the reticulo-endothelial system such as can be obtained
with mineral oils, and thioglyoollate medium and arachis oil,
SECTION 4). If this prolongation was therefore due to agent
inactivation this would show up as an even lower than usual estimate of
titre by the i.p. route than by the i.e. one when BRVR donor material
is used, but not when it is BALB material. Furthermore the estimates
of titre would be even lower still if the assay animals had been
pretreated with normal BRVR tissues.
While the incubation period changes can easily be thought
of in terms of general reticulo-endothelial activation, the lesion
profile changes cannot. As was mentioned earlier in this SECTION
it is reasonable to suggest that a higher lesion score in a particular
region of the brain is a reflection of higher agent activity there
(or in some other region functionally connected with it) so that the
tendenoy for BRVR normal brain treatments to raise the score still
higher, particularly in positions 5 and 6 could be due to greater
penetration of agent in those or associated regions. Such a model,
however, seems to require some kind of specific mechanism - as though
the exposure (including repeated exposure) to some antigen encourages
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a particular pattern of differential neuroinvasiveness. The difficulty
about specific mechanisms is that one would not expect them to work
in the isogeneic combination i.e. BRVR-passed ME7 should not show a
reduced neuroinvasiveness in BRVR mice, which it does. Such an
autoimmune type of reaction would, however, be explicable in terms of
responses to either sequestered antigens that have been exposed by
scrapie, or to scrapie-directed antigens, or to normal self-antigens
which have become immunogenic on account of an adjuvant effect of the
agent (rather in the manner proposed for the immunogenic RNA in some
hypotheses concerning the role of macrophage-processing of antigens
in the immunological response (Pribnow & Silverman, 1967; Bishop,
et. al., 1967; Fishman, 1970). The type of model one may envisage
for scrapie pathogenesis in the periphery involving specific
lymphoreticular reactions is as follows. Suppose that the agent is
physically associated, in both the spleen and the brain, with a
particular membrane structure (organelle or receptor) and that the
injection of infected tissue causes the initiation of clones specific
for that membrane structure (due perhaps to an adjuvant effect of the
agent) then sooner or later the specifically sensitised cells will
make immune responses of either a humoural or cellular type to these
antigens wherever they are found. Such specific antibodies or cells
would provide an agent with a highly convenient mode of transport to
its target sites. In this way agent associated with a particular
antigen in the donor could be carried to the same or a cross-reaoting
antigen in the recipient. (Perhaps the failure of some agents to
cross species barriers e.g. TMK to mice, could be due to the absenoe
of a suitable cross-reacting antigen, Hadlow & Karstad, 1968;
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Hanson, et. al., 1971).
A powerful argument against any such model is, of course,
the frequently demonstrated failures of immunological manipulations
to have any effect on scrapie inoubation periods. However, the
results desoribed in SECTION 4 with prednisone acetate indicate that
such effects are possible. If the population of cells concerned is
very resistant to most immunosuppressive regimes, requiring something
that borders on the level that will produce wasting disease, then
many treatments may have failed to reach this level, especially when
long ohronic courses of treatment were attempted. On the other hand
attempts to actively immunise in the case of sin agent which used
specific reactions to direct it to its target organ, may actually
encourage shorter incubation periods, although these would not be
detected if one was already using maximum doses in the interests of
speedy results, and they certainly would not have apy effect when the
agent was actually delivered to the arget organ by an i.e. injection,
as has sometimes been done in such experiments.
Another interesting possibility is that a condition such as
that postulated above could sometimes progress to a genuine
autoaggressive condition. Such may for instance be the case when
incubation periods run into decades rather than months or years e.g.
multiple sclerosis.
It has recently been shown that BRVR mice have the
lymphocyte-surface antigen while BALB/o and C57BL mice have the
antigen (Oliver, pars. comm.). Such antigenic differences could
underlie the results obtained in these experiments, and investigation
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of this possibility has begun.
Finally, it should be mentioned here that the notion of
speoifio responses by the lymphoretioular system need not necessarily
be confined to the well-known immunological responses; there is a
growing feeling that these may only be rather specialised versions of
a general morphostatic control system in the adult animal which governs
matters like relative organ size and repair mechanisms. This will
be dealt with further in the Final Disoussion in SECTION 7.
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SECTION 6
CHANGES IN THE DUNKING AND NEEDING HABITS OF NICE WITH SCRAPIE
- 129 -
CHANG-ES IN THE DRINKING AND FEEDING HABITS OF MICE WITH SCRAPIE!
In the phase of experimental scrapie when the mice are ill
there is a variety of obvious changes in behaviour. The details
vary considerably depending upon the strain of host and scrapie agent.
They can include: hyperexoitability, inco-ordin&tion of gait,
cessation of movement, somnolence, "freezing" postures when moved,
oiroling behaviour and, more rarely, pruritis. However, the very
variety and lateness of onset of these patterns consistent as they
are within particular combinations suggests that they must be a
consequence of secondary changes in brain physiology resulting from
scrapie infection, and as such are not likely to repay olose study
for information regarding the primary lesion.
While the olinioal phase of the disease oooupies the final
5 to 10$ of the incubation period, the rise in titre of the agent in
the brain can be detected from about 1/3 of the way through incubation
(Eklund, Kennedy & Hadlow, 1965; Dickinson, Meikle & Fraser, 1969;
Dickinson & Praser, 1969). Furthermore, the characteristic
histological lesions start to appear in the brain about half-way
through the incubation period with the host/agent combinations that
have been reported (Praser & Dickinson, 1968), though In some other
combinations, preliminary evidence indicates a relatively later
appearance of lesions (Praser, pers. comm.). These general
findings therefore raise the possibility of there being more subtle
behavioural changes occurring much earlier in the development of the
disease which could be detected by suitably sensitive means and may
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changes have already been made by Savage and. Field (1965) and Heitzman
and Corp (1968) using open field and emergenoe tests of behaviour.
These psiyohologioal tests are, however, rather too cumbersome for
routine use on a large scale and the physiologioal basis of them is
poorly understood. What is required is an early and oentrally
controlled change in behaviour which is easily and reliably assessable,
and which is well understood in neurophysiology. These criteria,
are more satisfactorily met by drinking and feeding habits than by any
other behaviour pattern and this SECTION desorlbed some ohanges in
these parameters in mice with scrapie. There is a possibility that
such behavioural changes could provide a basis for identifying the
primary biochemical lesion involved in agent replication.
In this SECTION it will be shown that alterations in
drinking behaviour occur with diverse strains of sorapie, genotypes of
mouse, routes of injeotion and with different stimulating solutes.
The ohanges are sufficiently consistent in these very different sorapie
situations to permit generalisations to be made. Some instances of a
less thoroughly explored change in feeding behaviour will also be
described although it has less generality than that of the drinking
change.
SPECIAL MATERIALS AND METHODS FOR THE DRINKING AND FEEDING EXPERIMENTS
In the combined accounts of numerous experiments which follow,
the following inbred strains of mice were U3ed: C57, A2G, VL, BALB, VM
and (C57xVM)F,j. Animals were between 4 and 12 weeks old at the time
of injeotion.
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Strains of sorapie agent. These are shown in Table 6.1 whioh
summarises some of their standard properties in C57, VM and F^ mioe,
with some of the principle differences in their lesion type and
distribution being illustrated.
Controls. The behavioural changes of the scrapie-infected animals
were compared with those of controls which were contemporaries of the
same age, sex and genotype. Two kinds of controls were used:
uninjeoted animals, or ones that had been injected by the same route
with normal brain supernates prepared from animals of the same genotype
as the sorapie-donor. In no experiment was there any evidence that
these injeations of normal brain had any long-term effect on behaviour,
and they certainly did not result in sorapie.
Measurements of changes in drinking and feeding. The mioe were all
housed in the environment whioh is desoribed in SECTION 2 - no special
provisions being made for this type of experiment apart from the use
of more rigid cage racks to avoid the loss of water by dripping from
the bottle spouts due to vibration. The quantities of food and water
consumed were assessed by weighing the food-hoppers and water-bottles
at intervals and calculating the average consumption per mouse per
day. The details of the weighing schedules varied a little from
experiment to experiment. Water bottles containing tap-water were
weighed 1, 2 or 3 times a week. In most experiments this tap-water
was temporarily replaced at intervals with a solution whioh had
previously been shown to produce a degree of polydipsia in the
particular strain of mouse. The periods of polydipsio stimulation
were either 48 or 72 hrs repeated every week or every two weeks.
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These periods of polydipsia (and aooomparying polyuria) were well
tolerated by most strains of mioe (in some oases the period of trial
was every two weeks for more than 600 days), but some, in particular
the VL strain seemed to go into urinary collapse if stimulated too
frequently. Such, animals, with or without early scrapie, will drink
as much as half their body weight per day.
Polydipsia-inducing solutions. Various solutions have been tried
and the following were used in the experiments.
- 2-%fo sucrose in tap water.
- 1/o sodium chloride in tap water.
- A mixture of l$> gluoose and 1$ saline.
The use of these generally doubled or trebled the fluid
intake of specifio strains of mioe during the periods of exposure.
RESULTS
Ex. 6.1 The response of C57 mioe to 2^1 auorose (72 hr. eveiy 14 days)
after a standard ME7 injection i.e. is shown in Fig. 6,1. The rapid,
progressive daaline in polydipsia response as compared with the
continued high responses of the controls, began about 7 weeks after
the injeotion and was therefore much earlier in onset than ar\y of the
clinical signs of illness. The period of illness is indicated by the
horizontal bar on this and subsequent Figures. The normal daily









period of clinical signs^
50 250150
days after injection
Figure 6.1 Drinking responses (2sucrose; 72 hrs. every 14 days)
of 17 057 mice after an i.e. dose of ME7 agent compared with the
responses of 18 057 controls injected i.e. with normal VM brain.
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Ex. 6.2 The sane agent (MS7) given i.e. to A2G mice produced an
essentially similar change in drinking (Fig. 6.2).
Ex. 6.3 A standard 79A injeotion i.e. in VL mice, although a quite
different agent/host combination, resulted in the same kind of ohange
in drinking behaviour (Fig. 6.3).
Ex. 6.4 Both the agents so far described (ME7 and 79A) belong to
the ME7-group, all of which give a shorter inoubation period in s7s7
mice than in p7p7. Another experiment showed that the same pattern
of drinking change could be obtained using the 22A agent in VI! mioe.
Thin agent is very different from the ME7 agent in that it produces
a shorter incubation period in p7p7 (i.e. VM strain) mice than in
s7s7 mice, and its use therefore provided a cheok on the generality
of the scrapie-produoed behavioural change. Two different
stimulating solutions were used in this VM experiment: 2^b sucrose
or \% NaCl in tap water (72 hrs every 14 days). The controls
received the saline only. Fig. 6.4 shows that the fall-off in
polydipsia response was the same with both stimulating solutions and
essentially similar to that described already in the s7s7 hosts with
ME7-group agents.
Ex. 6,5 The experiments so far desoribed in this SECTION used the
i.e. route of injection. This neoessarily resulted in some direct
damage to the brain, so the next experiment used a standard ME7
injection by the i.p. route into C57 mioe in order to avoid this
potential problem. Fig. 6.5 shows the changes in response to 2$>
















Figure 6. j drinking responses (2jf/o sucrose; 40 hrs. every 7 days)
of 6 VL mice, after an i.e. dose of 79A agent compared with the










Figure 6.4 Drinking responses of three groups of TO mice
(72 hrs. every 14 days). Responses of 11 TO mice to 1% saline after
i.e. injection of 22A agent; responses of 12 TO mice to 2lf/o sucrose









days after .In jei: I,lun
Figure 6.5 Drinking responses sucrose; 48 hrs. every 14 days)
of 10 C57 mice, after an i.p. dose of ME7 agent, compared with the










Figure 6.6 Drinking responses (tap water; average weekly
consumption) of 12 VL mice, after an i.p. dose of 79-A agent, compared
wi th 12 VL uninfected controls.
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combination using the i.o. route shown in Pig. 6.1. The delay in the
drinking change and the prolonging of the incubation period were
essentially of the same order? 60 and 55 days respectively.
Ex. 6.6 Another experiment using a standard 79A injection i.p. in
VL mice, in which changes in drinking ordinary tap water alone were
measured, gave similar results (Fig. 6.6). This, taken with the
similarities in responses to sucrose and saline shown in Fig. 6.4,
shows that the basic change is one in drinking and not a response to
the solute.
Ex. 6,7 Figs, 6.7-9 show that there is an important association
between the timing of the change in drinking and the aotlon of the
sine gene in controlling incubation period. Figs. 6.7 and 6.8 show
the effect of standard ME7 injections i.e. and the 22A agents
respectively on the drinking habits of 3 genotypes of mouse, C57, VM,
and their F. • Fig. 6.9 shows the responses of the C57 and VM controls
1
for these experiments - drawn separately for olarity. The oontrols
show an essentially level polydipsia response over many months.
All animals were stimulated with 2^ sucrose solution for 72 hrs every
14 days. A comparison of these graphs shows that the overall
drinking changes correlate directly with the oontrol that is exerted
by the sine gene upon the inoubation periods in parental genotypes also
being shown by the drinking responses, and in the difference in
allelic interaction with the two agents, inoluding the absenoe of
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Figure 6■ 7 Drinking responses sucrose; 72 hrs. every 14 days)
of three genotypes of mice after an i.e. injection of ME7 agent.
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days after injection
Drinking responses (as in Fig. 6.7) of the same three
genotypes of mice shown in Fig. 6.7 after an i.e. injection of 22A agent.
of
10
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days after injection
Figure 6.9 Drinking responses (as in Fig. 6.7) of 18 C57 and 10 VM
control mice, after an i.e. injection of normal VM brain.
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Ex. 6.8 The central control of drinking and feeding behaviour ia
inter-related in mammals. Figs. 6.10-12 show some results from
experiments in which the ohanges in weight of food eaten by sorapie
infected mice were measured. Three different agent/host strain
combinations are illustrated and they were ohosen for investigation
since remarkable ohanges in body weight had already been observed to
occur in them. Injections of ME7 agent into A2G and BALB mice
results in inoreases in body weight of mice of both sexes, while 22A
agent in VM mioe results in a long progressive emaciation.
Measurements were made of ohanges in drinking, feeding and body
weight in all three combinations.
The results in Figs. 6.10-12 are shown as a % of the oontrol
values as this permits a direct comparison of the timing of the
changes in the three features measured. In all three combinations it
can be seen that the ohanges in body weight are reflected by ohanges
in feeding behaviour. Animals in the phase of great over-weight show
considerable quantities of subcutaneous and peritoneal fat which
is probably mainly responsible for the extra weight. Of note too in
these ME7 systems, is the way in whioh the rise in feeding behaviour
occurs at nearly the same time as the fall in drinking with a slight
suggestion that the earliest phase of increased feeding is aooompanied
by temporarily increased prandial drinking. It should be strongly
emphasised that these marked early changes in feeding behaviour,
although very consistent for the agent/host strain combinations
described, are not a general occurrence. While most mioe show a
sharp fall in weight during the late olinioal phase, neither the sharp
























is common in the many combinations of agent and host that are used in
this laboratory* This is not a oase of the properties of a particular
agent, since the increases in weight shown by the A2G and BALB mice
with ME7 is not shown in numerous other strains of mice with this same
agent. Moreover, C57 and mice which show no particular change
with KE7 do increase in weight with 22A. Nor is it a property of
the mice, since the VM mice which show an early decline in weight
with 22k (Fig. 6.12) show a great inorease in weight with the 22C agent
(not shown). (gee also APPENDIX 1).
Hie fact that A2C and BALB mice are increasing their food
intake at the same time as they are reduoing their fluid intake,
further shows that the decline in drinking cannot be simply due to a
progressive difficulty in holding the head up or any other suoh
postural defect: both the food and water are supplied overhead and
require a similar physioal attitude to obtain them.
SECTION 6 DISCUSSION SCRAPIE MODIFICATION OF CENTRAL CONTROL OF
DRINKING AND FEEDINC
For a behavioural change to be of fundamental interest in
the pathogenesis of sorapie certain criteria have to be met.
Firstly, it must be the direot consequence of a primary lesion:
early changes are more likely to fulfil this criterion than late ones.
Secondly, it is of importance to be able to establish whether
sorapie-assooiated behavioural changes are of oentr&l or peripheral
origin. As already dlsoussed in SECTIONS 3 & 4 there is
considerable replication of agent in the lymphoretioular system and
this preoedes replication in the brain irrespective of the route of
inoculation (Dickinson & Fraser, 1969)• Apart from the finding of
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interference in the lymphoretioular system with an arbovirus
(Albreoht, 1970) no changes affecting the sorapie host's functions
outside the oentral nervous system have yet been reported. The
possibility remains, however, that there are a variety of peripheral
functional lesions resulting from the agent's replication. Thirdly,
the testing procedure that is used to deteot changes in behaviour
must not itself radically modify pathogenesis. Fourthly, since the
study of behaviour is such a complex matter, the parameter chosen for
study should preferably be already well characterised in fundamental
physiological researoh. The change in drinking behaviour of sorapie
mice, and to a lesser degree that of feeding, meet these criteria
and so provide a basis for a potentially fruitful researoh programme.
To the question of whether or not the modified drinking
response oould refleot a primary lesion in the central nervous system,
the earliness of onset and the wideness of the variety of host-agent
combinations which show it, strongly support this possibility. That
the change is not simply due to brain damage brought on by toxins
present in the inooulum is shown by the different timing of the ohange
when intracerebral (Fig. 6.1) and intraperitoneal (Fig. 6.5) routes
of injection were used and also by the delay of nine months before
intraoerebrally injected 22k began to affect drinking in s7s7 and
s7p7 mioe (Fig. 6.8). The modified feeding response, considered
apart from the drinking ohange, does not meet all the criteria needed
to establish a good likelihood of being a direot consequence of a
primary lesion. In the systems so far investigated (Figs. 6.10-12),
the feeding ohanges are of a variety of kinds, and until more diverse
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combinations have been studied, and the methods of deteoting its
onset have been refined, the matter cannot be resolved further.
The data, are not, however, incompatible with primacy, since
differences between the various agent/host combinations may be due to
differences in the timing of the arrival of agent in the relevant
brain centres. The earliness of the feeding changes and the fact
of the inter-relatedness of the controls of drinking and feeding
functions in the normal animal (Leibowitz, 1971) both justify the
inclusion of the feeding change in the enquiry.
That the drinking change is due to oentral rather than
peripheral lesions is made likely by the results for intraperitoneal
injection and by the apparent close association with the basic effect
of the sine gene. If the effect of the agent on drinking had been
peripheral, one would have expected the onset of the behavioural
change to be at the same time irrespective of the route of injection,
because it is known that the initial rise in titre of ME7 agent in
the spleen of s7s7 mioe is at almost the same time for both routes
of injection (Dickinson & Fraser, 1969) and, by inference, the same
would be expected in other peripheral sites, although no data are
available. In fact, the delay in the onset of reduced drinking
(Pig. 6.5, of. Pig. 6.1) is almost the same as the increase in
incubation resulting from the peripheral injection.
Prom the results where different sine genotypes were used
(Pigs. 6.7-8) it is evident that variation in the timing of the start
of the drinking change is to a very large extent controlled by the
sine gene. This gene appears to act on agent replication in eaoh
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tissue (Diokinson & Meikle, 1971). On the basis of the limited
available evidence concerning the timing of replication in the brain
of the various agents in the different genotypes used (Dickinson,
Meikle & Fraser, 19^9} and Dickinson, pers. ooam), it seems likely
that the drinking decline, the increased feeding (Fig. 6.10-12), the
astrocyte hypertrophy and the vacuolation of brain tissues all
oommenoe at about the same time that agent replications start in the
brain.
It is concluded therefore that the results lndioate that the
change in drinking (and possibly the changes in feeding) are due to
some very early biochemical lesion in the central nervous system and
not to some peripheral damage.
Seen in the light of present day neurophysiology these
results have both theoretioal and praotioal significance. At the
theoretical level the identification of a biochemical lesion close to
agent replication could be of the utmost importance in understanding
the disease. Y/hile on the practical level, these results show that
a large number of the techniques and theoretioal models of the
neurophysiologist are now available for scrapie research. Feeding
and drinking are probably the best understood aspects of oentrally
controlled behaviour in mammals although there is still a great deal
of disagreement about the details amongst research workers. The
employment of some of the established techniques for modifying
drinking and feeding in scrapie animals compared with their effeots
on normal animals might lead to the identification of the primary-
biochemical lesion.
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It would not be profitable to speculate at great length upon
all the theoretical and practical possibilities that are thus opened
up: they are too numerous, but some tentative suggestions regarding
the more important possibilities will be made. There are clear
resemblances between the reported behaviour patterns in scrapie
animals and the changes brought about by experimental stimulation or
destruction of certain brain oentres. The literature on this
subject is now vast and has been reviewed recently by Morgane (19^9)
and Hoebel (1971). However, the generally benign nature of the
observable lesions in scrapie, especially in the early stages of the
disease are suggestive of some subtle kind of failure of cell
communication such as synaptio derangement rather than extensive
breakdown of funotion. It is also no longer proper to look for such
lesions exclusively in the hypothalamus: the earlier views that
feeding and drinking were controlled by activity and satiety centers
in this region (for example, Anend A Brobeok, 1951; Anand, 1961;
Hetherington & Ranson, 1940; Montemurro A Stevenson, 1957;
Larsson, 1954) have been superseded by ' neu ral circuit* theories
which involve limbic and other extrahypothalamic areas (Grossman,
1968; Grossman, 19^9; Milgram, 19^9; Lorens A Kondo, 1969;
Singer & Montgomery, 1970). In any case, vacuolar lesions in
sorapie mioe (assuming that these also refleot the primary lesion,
which they may not) show that damage 00ours in many regions of the
brain (Fraser A Dickinson, 1973) end hypothalamic lesions are
relatively minor in some host-agent combinations (Dickinson, 1970;
Fraser, 1971). One example of a recently developed set of techniques
in neurophysiology which could be used in sorapie research is the
- 150 -
stereotactically controlled injection of putative transmitter substances
and their respective anatagonists into discrete areas of the brain
(e.g. Grossman, 1962; Margules, 1969; Leibowitz, 1970a, 1970b, 1971)•
Leibowitz has shown, for instance, that a decrease in drinking and
an increase in feeding (cf. Fig. 6.10, 11) can be obtained in rats by
hypothalamic injections of either an alpha-agonist (e.g. norepinephrine)
or a beta-antagonist (e.g. propranolol HC1; see also Lehr, et. al.,
1967). This work clearly provides some testable hypotheses for
scrapie as an agent of synaptic derangement.
The behavioural changes reported here and the variety of
signs which develop in the clinical phase are compatible with what
one would expect to happen if the central nervous system was infeoteG
by an agent which slowly and progressively put out of operation a
single class of synapse. There is an increasing number of putative
transmitter substances and their respective post-synaptic receptors
(acetylcholine, epinephrine, nor-epinephrine, 5-hydroxytryptamine,
histamine, dopamine, gamma-aminobutyric acid, glycine etc.) some with
a fairly looalised distribution and function (e.g. dopamine in the
neostriatum and tuberculum olfactorum) and others more widespread in
the brain and cord (e.g. norepinephrine and 5-hydroxytryptamine, Fuxe,
1965). One may include also: prostaglandins, polyamines,
phosphatidyl inositol, and some oligopeptides which have been
suspected of various supporting roles in synaptic transmission
(Sano, 1970; Snythies, 1972; Hadquist, 1970). A creeping
derangement of such a system could probably be compensated for to 3ome
extent by brain repair and homeostatic mechanisms (Green, et. al., 1972),
with the result that animals would show no obvious signs of upset until
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the resources for compensation ran out, with a consequent outburst of
terminal clinical signs. This "type of hypothesis would allow for
the numerous minor variations in behavioural 3igns due to agent/host
strain combinations by postulating differential damage (as reflected
in lesion profiles) as a result of different distributions of
classes of synapses according to ho3t strain and different rates and
sites of penetration by each agent. A major difference in sorapie
pathogenesis, however, such as that produced by different alleles of
sine could only be acoounted for in these terms by a fundamental
difference at the level of transmitter substance or synaptic mechanism.
The complete reversal of the incubation periods for the 22A-
group and the KE7-group of agents in s7s7 and p7p7 genotypes
(Dickinson, et. al., 1968; Dickinson & Meikle, 19^9; Dickinson &
Meikle, 1971) stems directly from the most primary effect so far known
in sorapie, namely the interaction of the agent with a product of the
sino gene to permit agent replication. Further evidenoe that agent
replication is restricted to a limited number of cellular sites, which
may be specified by the sino gene comes from evidenoe for competition
between different sorapie agents during pathogenesis of mixed
infections (Dickinson, Fraser, Meikle & Outram, 1972). In neu ral
tissue, 3ome of these postulated replication sites may be linked to
ones affeoting eating and drinking by only a short chain of cellular
events. An examination of the s7s7, s7p7 and p7p7 mioe in terms
of synergisms and competition between scrapie agents and pharmacological
treatments, for instance, could possibly expose this chain and thereby
throw light upon the nature of the scrapie agent or its mode of
replication.
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A histological examination of the distribution of vacuolar
lesions in A2G mice after i.e. MF.7 scrapie at the time when the
drinking and feeding changes are beginning is reported in full in
Appendix 4. Briefly, it is shown that no lateral or ventromedial
hypothalamic vacuolar lesions oocur at this early period in this
combination, and that the earliest vaouolations are found in the dorsal
hypothalamus, the perifollicular region, the hippocampus and later in
the amygdala and septum (paraterminal body). Had there been any
marked association of lesion distribution with the classical lateral
and ventromedial hypothalamic feeding and drinking control centres
this would have constituted strong evidence for a direct relation
between these lesions and the behavioural defects due to scrapie.
The observed distribution, however, tells us very little and perhaps
adds to the suspicion that these, the best known and most easily
demonstrated CNS lesions of scrapie, have little to do with the
primary damage and are themselves a secondary effect of something
more fundamental. There are well defined instances in which sheep,
given experimental sorapie and showing all the classical olinioal
signs, do not show any vacuolar lesions (Dickinson, pers. comm).
This suspicion does not, of oourse, diminish their diagnostio and
disoriminant value in the form of lesion profile analysis, although
it would reduce their relevance for a fundamental understanding of
scrapie.
However, the observed distribution of vacuoles could still
relate to the oause of the ohanged drinking and feeding behaviour,
because regions like the hippocampus, amygdala and septum have all
been implicated in theories of modulatory control of the hypothalamic
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centres, although much less is known of their mode of action. The
septum, in particular, has featured frequently in recent experiments
demonstrating changes in drinking and feeding of rats after lesion
(Singer & Montgomery, 1970; Harvey & Hunt, 1965; Sorensen & Harvey,
1971; Altman & Wishart, 1971). There are also sex-differences in
the degree of response to septal lesions and this provides another
possible reason for the effect of sex upon the inoubation period of
scrapie (Appendix 3)« (Kondo & Lorens, 1971; Lorens & Kondo, 1971)•
Also of interest is the demonstration by Leibowitz that stereotaotic
administration of adrenergic drugs in the dorsomedial hypothalamus
and the perifornieular region of the rat can affect feeding behaviour
(Leibowitz, 1970). It can be seen that all the areas where early
lesions occur in this particular combination of ME7 agent and A2G- host
strain have also been shown to have some potential function in the
control of drinking and/or feeding, although apparently at one remove
from the primary hypothalamic control centres. It remains to be
seen if correlations will be found in other sorapie combinations which
show different patterns of behavioural change and overall lesion
profile.
The strong resemblanoes between the temporary patterns of
behavioural change which Leibowitz and others have been able to
produce in rats by stereotactic injections of adrenergic hormones
their analogues and blockers, and the permanent and progressive changes
shown by scrapie mice, suggests the possibility that the biochemical
lesion produced by scrapie may involve the catecholamines. If these
are also related to the action of sine then they could be very
interesting indeed.
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There are other observations pointing to the possible
involvement of these amines. The apparent effect (Ex. 4.15) of the
catecholamine-depleting drug 6-hydroxydopamine is one. It is
interesting that the motor defects reported in rats after 60HDA
injections along the medial forebrain bundle are similar to clinical
signs observed in some sorapie combinations (e.g. i.e. 79A in DBA/2):
weak, hypotonic hind limbs which are dragged behind, spinal flexion,
hyperresponsivenes3 to stimuli, pronounced aphagia and adipsia
(Smith, et. al., 4 972). Ventricular injeotions of 60HDA also cause
reduced responsivity to polydipsic solutions of sucrose (Sorenson,
et. al., 1972).
It has also been shown in the case of several virus enceph-
alitides in mice that monoamine metabolism is seriously disturbed
(Lycke, et. al., 1970). A great reduction in the levels of
dopamine and norepinephrine have been reported in a case of
Creutzfeldt-Jakob disease (Brun, et. al., 1971).
For the catecholamines to have any relation to sine one
would expect some use of them by cells of the lymphoretioular system
since this gene appears to control the onset of sorapie replication
in these tissues as well as in the brain. As yet there seems to be
no strong evidence that epinephrine, nor-epinephrine (or dopamine)
are implicated in •immunological* funotions, although another biogenio
amine, 5-bydroxytryptamine, has (Devoino & Yeliseyeva, 1971).
Also a mixture of epinephrine and propiomazine impaires immune responses
(humoural and cellular) and causesrunting when injected into neonatal
rabbits (Henson, et. al., 1968; Henson & Brunson, 1969a)
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and prevents experimental allergio encephalomyelitis (EAE) in adult
rabbits (Henson & Brunson, 1969b). Nor-epinephrine (an alpha-agonist)
augments PHA-induced ^H-thymidine incorporation by lymphooytes, while
phentolamine (an alpha blocker) prevents this augmentation, so that
it is oonoeivable that an alpha-blooking agent oould alter oellular
immune responses (Hadden, et. al.# 1970). Lastly, by way of
exemplifying the possible implication of these substances in immune
responses, is the observation that the adenyl cyclase of mouse and
rat lymphoids! cells is aotivated by both epinephrine and norepinephrine
(Makman, 1971).
As a way of testing quite simply if sorapie impairs the
metabolism or transmitter function of the catecholamines some
experiments are in progress to investigate if the behavioural responses
of sorapie mice to periodio peripheral injections of drugs known or
suspected of acting via oentral mechanisms are in any way different
from the responses of normal mioe. Numerous alpha- and
beta-agonists and antagonists were tested in a preliminary way on
several strains of mice. At present two of them are being used.
Amphetamine is a potent produoer of transitory aphagia probably by
beta-stimulation and inhibition of re-uptake of epinephrine. Its
effect on the hyperphagia of A2G- mioe with ME7 is being tested.
Thyroxine (apart from its many other effeots) is also suspected of
central action in the oontrol of catecholamine function. Emlen,
Segal & Mandell (1972), postulate that thyroxine may bring about
'receptor tuning' for nor-epinephrine, so that increased concentration
of the thyroid hormone lead to an inoreased receptor sensitivity.
Accordingly a change in responsiveness to the effeots of thyroxine
on feeding and drinking behariour is being sought in experiments
with scrapie mice. Home Office permission has been requested in
order to do scheduled drinking experiments in which sorapie animals
will not be given food and water simultaneously, whioh should enable
a distinction to be made between ohanges in prandial and physiologioal
drinking.
This SECTION has reported a change in drinking behaviour in
sorapie mice of wide generality which, especially when taken with the
feeding change shown by a minority of combinations, suggests that an
early biochemical lesion of scrapie interferes with central cellular
communication using the catecholamines, epinephrine and nor-epinephrine.
More direct evidence for this is being sought which could form the
basis for an understanding of how sorapie agent oould cause this kind






The results of SECTIONS 3-6 have already been considered in
their respective Seotion Discussions, and so it only remains to ask if
they can be synthesised into an overall model and if there are possible
types of explanation other than the immunological one whioh has been
generally adopted in this thesis.
The intention of the work reported has been to try to
identify some new primary aspects of the pathology of experimental
scrapie in the mouse and to explore them as far as possible in the time
available. Tactical considerations - notably the need to take
precautions against getting deflected into a time-consuming pursuit
of one of the many seoondary effects of the disease - dictated a
polioy of having several relatively independent lines of investigation
in which apy interesting findings would be tested for wide generality
as soon as possible in a variety of agent/host strain combinations.
Four such independent experimental lines have been described. In the
case of those relating to the effects of age and a number of
lymphoreticular-reactive drugs on the inoubation periods of i.p.
injected agents, the results oan be easily harmonised in terms of
imbalances of cellular components of the lymphoreticular system at the
time of infection. An attempt has been made in SECTION 5 to extend
this model to include the possibility that pathogenesis may also
require some specifio responses of an immunological kind. It was
suggested that agent may be directed to its target sites by
'immunological aiming' derived from an initial sensitization to
sorapie-assooiated donor antigens. However, it must be admitted that
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while there is still doubt about the identity of the ME7 agent in the
two sub-lines there must also remain some uncertainty that the
modifications in pathogenesis were entirely due to donor-tissue
components and not to two slightly different agents. In the end,
of oourse, the question may hinge on just what constitutes an agent
and what a host-component.
The behavioural changes reported in SECTION 6 have the
strongest olaim of all the results in this thesis to be olosely
related to the actions of the sine gene. The evidence suggests that
the drinking change is due to some progressive derangement of a
function of sino in the CNS, but the class of upset has not yet been
identified. Reasons have been given for suspecting that they oould
be due to a breakdown in adrenergic synaptic communication, and it
would dearly be of great interest if it could be shown that this was
the sphere of operation of sino. However, the association of scrapie
with these amines is only very tentative and furthermore, their little
understood involvement with the lymphoreticular system (See SECTION 6)
precludes anything but the most speculative synthesis of the drinking
observations with those of the age- and PA-effeots.
The generality of the age-effect and the PA-effect has been
tested in a variety of agent/host strain combinations but in neither
case has this been done in a long-incubation period type of
combination. It will be appreciated that to add a prolonging treat¬
ment (which most are) to a long-incubation period combination,using
agent injected by a peripheral route, oould lead to experiments in whioh
the animals died of old-age before showing ary clinical signs. In
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such circumstances it would be necessary to resort to •blind passage*
and serial titrations at, say, six-monthly intervals, in order to
detect the effects of treatment. These are amongst the next
generation of experiments and therefore cannot be reported here. The
results of this type of experiment would be expeoted to give some
strong indications of whether or not the age- and drug-induced
modifications of scrapie pathogenesis operated through some disturbance
of sino function. Meanwhile, however, it is justifiable to devise
some experimental programmes on the assumption that sino is implicated
in these results and to look for indications of a common biochemical or
physiological basis for all classes of phenomena reported in this thesis.
Suoh an approach also requires a readiness to entertain several quite
different kinds of explanatory models simultaneously.
Before considering some samples of these it is relevant at this
point to refer to a recent finding of a kind which may have a bearing on
some results in this thesis but which is too recent to assess. It will
serve to illustrate the possibility that quite simple new discoveries can
still put an entirely new complexion on previous findings. It has
been shown that tissues,both from animals with scrapie and persons with
multiple sclerosis, contain a replicating faotor which causes a rapid
decrease in the proportions of polymorphonuclear neutrophils amongst
the circulating leucocytes of mouse recipients (Licursi, et. al., 1972;
Carp, et. al., 1972). Collaborative investigations in this laboratory
have shown this faotor to be present in a wide range of scrapie agents.*
Evidence indicates that this factor is not the same as the infeotive agent
of scrapie and has properties differing from sorapie agents in important
* Pers. comm. Carp, Dickinson, Licursi and Taylor.
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respects: whether it is an autonomous product of scrapie infection or
only in specific secondary association with scrapie is not known.
However, it must he assumed that this factor was present in most if
not all of the experiments reported in this thesis. As its only
known effect is to alter the differential leucocyte count it could
clearly he involved in several of the responses,although whether it is
relevant to the interpretation of any of the results cannot at present
he judged. This finding shows how important it still is in scrapie
research to emphasise operation descriptions of findings and to avoid
a premature commitment to one particular explanatory model.
In fact, none of the results which have been desorihed in
previous SECTIONS point irrevocably to the immunological model which
has so far been adopted. As an indication of other possibilities a
brief description will be given of two alternatives which have some
attractive features of their own.
The enzyme pherylethanolaiaine-N-methyl transferase (PNMT),
which catalyses the transmethylation of norepinephrine (NE) to
epinephrine (e), usually requires for its induction, very high
concentrations of gluoocortioosteroids. This is achieved in the adrenal
(mammalian)medulla by a portal system which carries the steroid directly
from the adjacent cortex. However, the conversion of NE to E also
occurs in other organs (e.g. the heart and brain) without the benefit
of these high concentrations. This is also the case in some
E-secreting phaeohromocytom&s, and in other vertebrate classes in whioh
the medullary and oortical components of the adrenals are anatomically
di3tinot. There is some evidenoa that this enzyme can exist in
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several forms with different induction thresholds. High levels of
PNJCT and hence of E-produotion can also be produced by injeotions of
large doses of gluoooortioosteroids. Such injections in neonatal
rodents also result in the retention and even hypertrophy of the
foetal extra-chromaffin tissue which surrounds the sympathetic chains
of the trunk (e.g. the organ of Sukerkandl) and generally atrophies
soon after birth. The function of this tissue appears to be unknown,
but in view of the new-found associations between adrenal development
and that of the thymus and hence the lymphoidal system as a whole
(Pierpaoli and Sorkin, 1972b & c) it is possible that this tissue has
a role in this sphere. This intriguing subjeot has been fully
reviewed recently by Pohorecky & Wurtman (1971)• These observations
regarding the role of corticosteroids in the induction of a
catecholamine-metabolising enzyme and in the hypertrophy of tissue
containing it, make possible another type of model of the age- and
PA-effects. Suppose that in both the neonatal mouse and in older
animals after PA-treatment, there is an extra large volume of
catecholamine-metabolising tissue in the abdominal cavity. Such
tissue, by virtue of its resemblance to sympathetic neurons could aot
as a 'diversion' for i.p. injected sorapie agents - especially perhaps
if the animals also have a greatly reduced lymphoidal system (whioh
may normally be able to transport the agent away to other sites in
the retioulo-endothelial system). Such a fate for the agent could
be a form of 'inactivetion' covered by the rubrio in SECTION 3s
'sequestered in some alternative tissue where it cannot replicate,
do damage or gain aooess to target cells'. This kind of diversion
would at least result in longer incubation periods and perhaps lower
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estimates of titre. Liberation of agent when suoh tissue eventually
atrophies may result in the 'late oases' often found in experiments
of this kind.
This model has certain attractions: it easily accommodates
the PA-effect as a oonsequenoe of a temporary restoration of a
neonatal condition; it provides an explanation for a loss in titre
which does not depend on destruction of the agent; it is easily
disproved by experimental investigation; PNMT is the kind, of enzyme
whioh the sine gene could conceivably be involved with; and the
connection with cateoholamine-metabolism is obviously relevant in
connection with the behavioural changes. However, it is difficult to
see how such a model could provide for any degree of specificity suoh
as seems to be required in the BALB/BRVR phenomenon. It is also
perhaps improbable that suoh a large loss of activity with so many
survivors could be obtained by such a mechanism.
Another hypothesis which is interesting in that it provides
for speoifio reactions by elements of the lymphoreticular system but
without invoking the conventional immunological responses is suggested
by the discussions of Pierpaoli & Sorkin (1972a) in which they reopen
the old question of the primary role of the lymphoidal system. Over
the years there have been several objections to the prevailing view
that the sole function of this system is that of detecting and
removing exogenous foreign antigens (e.g. Yoffey, 1962; Loutit, 1962;
Burwell, 1963; Buroh, 1968; Burnet, 1970; Bullough, 1971). These
writers insist in various ways that the well-known immunological
funotions of lymphooytes are simply specialised off-shoots of a more
- 164 -
primary function such as •surveillance* or 'morphostatic control'.
Such hypotheses provide attractive alternatives for the mode of scrapie
involvement in lymphoreticular functions. It has frequently been
pointed out by scrapie workers that the pathogenesis of scrapie has a
certain inexhorableness, and some have remarked that it does not
resemble a disease so much as a growth process (Dickinson, pers, comm.).
Should it turn out, therefore, that functions like the maintenance of
inherited bodily proportions and the readjustments of organs to stress
or injury (e.g. the hypertrophy of one kidney after the removal of the
other) is a function of the lymphoidal system, then it is not difficult
to 3ee that the linking of scrapie replication to this type of system
could provide it with the regularity that is observed. This would be
especially true if the system in question was of central importance in
the maintenance of life so that it could not be tampered with without
fatal results to the host. Particularly attractive from the
theoretical point of view, is that the morphostatic hypotheses require
the operation of various tissue-specific affector and effector
moleoules, for which more and more potential candidates have recently
been found. The affector molecules are envisaged as informing the
oentral control (?thymus) of the status quo (and hence of ohanges
to it), while the effectors would direct aiy necessary adjustments,
(e.g. by restarting oell-division in appropriate tissues). Amongst
the best known substances of these types at the present time are the
lymphokines such as lymphotoxin, macrophage migration inhibitory
factor, maorophage aggression factor, transfer factor, skin reactive
factor, the interferons, tissue-specific ohalones, and the wide range
of substances extraotable from salivary glands of which the best known
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is the nerve growth factor. An association of scrapie with one or more
of these types of informational molecules, whether at a simple plysioal
level, or more subtly by something like episomal interference of their
transcription (in the manner of lysogenie phages), could provide a
degree of tissue specificity which would permit 'immunological aiming*
and the general repeatability of lesion profiles. In fact, if
scrapie agents were molecules very similar to these kinds of information
molecules it oould account for their ability to evade the host's
immunological responses. It would also permit the construction of
interesting cybernetic models for agent replication. For instance,
the overloading of a homeostatically controlled system with exogenous
informational moleoules oould lead to positive feedback oscillation in
which the overswing responses made during the attempts to restore the
status quo led to the production of more agent by the host. This type
of pathogenic pattern should be detectable by looking for oscillatory
phenomena in the preclinical phase in a variety of host systems
(including behaviour patterns and perhaps EES cycles),
It is stated in the introduction to this thesis that there is
as yet no agreed methodology or theoretical framework in the field of
the 'slow-viral encephalopathies' and in such circumatanoes it is
dangerously easy to indulge in speculations beyond the point of
practical scientific usefulness. It is important therefore, to olose
this Final Discussion on a more sober and realistic note, A number
of findings have been reported which show that it is possible to
modify the pathogenesis of peripherally injeoted scrapie agents in
mice, both in terms of incubation period and lesion profile. This
contrasts with the rauoh greater difficulty in doing so with centrally
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injected agents, although the effects of aotinomyoin D on incubation
periods and of donor tissues antigens on i.e. profiles (Outram,
Fraser & Wilson, 1973) look promising. However, -this relative ease
of modification of peripheral pathogenesis raises the possibility
that the methods are operating on 3teps that are not controlled by
the sino gene, so that although they may offer some hope for the
discovery of prophylaotio treatments by throwing light on the early
stages of infeotion, they may be less useful for elucidating the
nature of agent replication, and henoe for the disoovery of cures.
Alternatively this relative ease of manipulating peripheral pathogenesis
may simply be due to a greater aooessibility of the extraneural sites
of interaction between agent and sine gene, in whioh case further
investigations of these findings oould result in an identification
of the normal role of this gene and henoe of the nature of its




APPENDIX 1. BODY WEIGHT CHANGES IN MICE INFECTED WITH SCRAPIE AGENTS.
Prom time to time there have been reports of body weight
changes in sorapie-affeotedL sheep (Stamp, 1962; Daniel, 1971) and
mice (Field, 1969)* With outbred populations, conspicuous examples
of over- or underweight occur in isolated individuals only. With
inbred populations of mice, however, they appear to characterise
certain agent/host strain combinations. In the experience of these
laboratories such weight changes are the exception rather than the
rule - most scrapie infected mioe showing only a brief terminal
phase of rapid loss in weight. Figure A1,1 shows the body weight
data for a number of agent/host strain combinations. They
illustrate both the oommon pattern (e.g. 79A in A2G and BALB mice and
ME7 in C57 mice) and the occurrence of large increases in weight well
before the terminal phase (ME7 in A2G- and BALB mice and 22C in VM mice)
and long periods of a slow decline in weight (22A in VM mice).
The physiological basis of these weight ohanges is not
known. In the oase of A2C and BALB mice injected with ME7 agent, it
has been shown that the increase in weight is accompanied by increased
food consumption (SECTION 6) and it is reasonable to assume that one
is the cause of the other. However, it is possible that there are
also metabolic modifications such as changed metabolic rates, or
raised setting of homeostatio oontrols of body weight/""increased
conversion of carbohydrates to lipids. These alternatives have not
yet been investigated.
Perhaps the most likely root cause of these agent/host
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strain differences in body weight responses (as in the case of
lesion profiles), is a particular pattern of agent infection in






































Figure A1.1 Body weights (gms) of four strains of mice injected
at weaning with various strains of scrapie using the i.e. or the i.p.
route. Body weights of controls shown by broken line.
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APPENDIX 2. AN INVESTIGATION OF THE EFFECT OF A SINGLE S.C. DOSE OP
500 mg/kg OF PREDNISONE ACETATE ON THE WEIGHT OF THE
THYMUS AND SPLEEN. AND THE DIFFERENTIAL LEUCOCYTE COUNT
IN VL MICE
Large doses of prednisone acetate (PA) have been shown to
modify the pathogenesis of sorapie agents in mice (SECTION A).
Cortisone acetate has been shown to have a profoundly depressing
effect upon the weight of organs of the lymphoreticular system and
upon the numbers of small lymphooytes in the blood (e.g. Elliott &
Sincleir, 1968). Since such an effect could be the basis of the
prolongation of scrapie incubation periods by PA, the following
preliminary investigation was performed to find the gross effects of
this steroid on the lymphoretioular tissues of VL mice.
Materials and Methods. Male and female VL mice ranging in age from
20 to 100 days were injected s.o. with PA (500 mg/kg suspended in
isotonic saline) or saline only. Every individual was weighed at the
start and at weekly intervals until killed. Groups of animals, each
including a range of ages, were killed on the 4th, 7th, 14th and 21st
day after the steroid injection and the following data obtained:
- body weight at the time of death;
- weight of spleen, thymus and brain;
- two blood slides (retro-orbital) for differential
leucocyte count;
- peritoneal washout.
Blood slides were stained with Wright's stain and differ¬
ential counts made of 200 leucocytes per slide using the following
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categories? small lymphocytes, large lymphocytes, polymorphonucleooytes
and monooytes.
The peritoneal cavity was filled immediately before killing
with 2 ml. of heparinized saline. The abdomen was gently massaged,
the mice killed by cervical fraoture, the peritoneal contents
pipetted into plastic containers and kept ice-cold until counted
using a Neubauer chamber. A distinction was made between 'small
oells' (= mo. stly small lymphocytes) and 'large cells' ( = large
lymphocytes, and polymofphonuoleooytes).
The spleen, thymus and brain were removed, blotted and
weighed.
Results. The PA injections had only a slight and transitory effect
on whole body weight and none on brain weight - these results are not
reoorded here.
Fig. A2.1 shows the spleen weights before and after PA
treatment. These were severely depressed in females for at least
7 days, and in males for between 4 and 7 days after injeotion. The
thymus weights of the same animals are shown in Fig. A2.2. The
normal deorease in weight with age is well-shown and the depressive
effect of the steroid injection is apparent for at least one week and
up to two weeks in the case of one female. The degree of depression
appears to be maximal irrespective of age.
Differential leueocyte oounts are shown in Fig. A2.3. The
values for monocytes are not shown but remained within the-5-1JD^ mark
throughout. No significant modification of the proportions of large
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lymphocytes were deteoted either. However, there was a marked decrease
in the proportion of small lymphocytes and a corresponding increase
in polymorphonucleocytes, Although no total count was performed
there can be no doubt that the inoreased proportion of
polymorphonuoleocytes also represents an absolute increase in numbers:
sometimes it was difficult to find any small lymphooytes on the
slide at all while polymorphs were densely distributed all over the
slide.
Peritoneal washouts after the s.c. PA injection showed the
same initial depression in absolute number (Fig. A2.4) with evidenoe
of considerable increase in numbers of the larger cells (probably
polymorphonucleooytes) in some individuals by one week after injection.
The small lymphocytes, however, remained depressed even three weeks
later, suggesting that prolonged courses of steroid injection could
keep the peritoneal cavity depleted of these cells for a long period.
These results oonfirm that PA has the same general lympho-
retioular depressing effeots that have been reported for cortisone
acetate. The evidence of a long term unbalancing effect upon the
proportions of peritoneal cell types supports the models for the
PA-effeot which are described in SECTION 4, Further investigation
of the modification of scrapie incubation periods by PA, arachis oil,
6-hydroxydopamine and phytohaemagglutinin (SECTION 4) will obviously
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Figure A2.1 Spleen weights (mg.) of female and male VL mice at
various ages from weaning to atout 4 months old.
The ringed numbers represent the spleen weights of mice when
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Figure A2.2 Thymus weights (mg) of female and male VI mice at
various ages from weaning to about 4 months old.
The position of the ringed numbers represents the ,
thymus weights of animals treated with 500 mg/kg of PA and the number
indicates how many days after the steroid injection the individual
was killed.
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Small lymphocytes Polymorphonucleocytes Large lymphocytes
1°
N 47 14 21 N 4 7 14 21 N 4 7 14 21
Figure A2.3 Differential leucocyte counts in the blood of VL mice
normally (n) and 4>7>14 and 21 days after a s.c. dose of 500mg/kg PA.
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x 10,000 cells/ml
N 4 7 14 21 days after PA
Figure A2.4 Cell counts in 2ml washouts of the peritoneal
cavity of normal (N) and PA-treated VL mice, 4»7»14» and 21 days after
injection.
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APPENDIX 3 THE EFFECT OF SEX OF RECIPIENT ON THE INCUBATION PERIOD
OF DIFFERENT AGENTS
Some early results using the 79A agent by the i.p. route
showed a marked difference in inoubation period according to sex.
This prompted an analysis of the results from numerous experiments
performed in previous years in these laboratories and using a variety
of agent/host strain combinations. The incubation periods from
several different experiments performed at different times, but using
essentially similar operational conditions, were combined to obtain
the overall means which are shown in Table A3.1. The results from
other subsequent experiments especially using 79A have been added.
The significances of the incubation period differences were obtained
by simple t-test.
Comments It can be seen that inoubation periods are usually
significantly longer in males than in females for the agent/host strain
combinations that were investigated. However, this was not the case
for the ME7 agent in several genotypes and using both the routes of
injection, although the mean incubation period for males tended to be
longer than that of females at high dilutions in titration experiments.
The oause of this differenoe is not known at present. A
careful examination of the laboratory records excludes certain
possibilities such as: bias due to the strain or s ex of donor, or to
a scoring tendency of certain observers. The magnitude of the
sex-effect depends upon the strain of agent and recipient, and the
route of injection.
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It is not known if the generally prolonged male inoubation
periods as compared with those of females represents different
operational titres, different rates of replication, or different
host resistance to damage leading to a delay in the onset of olinioal
signs. A comparison of the lesion profiles (not shown) for males
and females in some of the combinations indicates that they are very
similar and so does not suggest any preferenoe for any of the above
possibilities.
It is perhaps worth noting, however, especially in view of
the emphasis that has been laid in this thesis upon the possible
association of scrapie replication with immune functions, that female
mammals generally show stronger immunological responses than males as
well as higher incidences of autoimmune conditions and sequalae, and
diseases suspected of immunological involvement such as Multiple
Solerosis (Poskanser, 1965; Graff, et. al., 1969; Galton, 1967;
Dresser, 1962). It could be therefore, that the more efficient
immune system of females whioh stands them in good stead for
conventional infections acts against them in the oase of agents whioh
make use of the immunological system for their pathogenesis.
However, since nothing is as yet known about the rates of
replication of agent in the two sexes, or even of the comparative
titre in terminal brains, other possibilities remain. For instance,
it is known that there are pronounoed differences acoording to sex in
feeding and drinking responses after damage to brain areas, in
particular the septum (Kondo & Lorens, 1971) so that it is possible
that identical titres of agent in animals of either sex could cause a
different timing of the onset of olinioal signs and hence of e stimated
incubation period.
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RIII i.e. 13611 140+1 XX
C 51 13812 14111 XX
SM 1Z»8±1 150+1 -
VL 151±1 155H XX
C57 152±2 157+2 -
A2G 160+1 166+1 XX
BALB 161±1 166+2 XX
RIII i.p. 189±1 195H XXX
C3H 195H 202+2 XXX
SM 20411 20712 -
VL 205±1 221+1 XXX
C57 201+2 20713 -
A2G 197±1 20311 XXX
BALB 227+3 232+3 -
057 i.e. 10~2 159±1 156+1 m
10"3 16311 166+2 -





10 220+6 23314 -
A2G 161+2 166+3 -
VM 322±3 326+2 -
F. (a7p7) 2AA+2 24612 -
057 i.p. 27914 282+4 -
A2G 23213 23513 -
057 i.o. 17411 181+1 XXX
VM 433110 43414 -
057 i.e. 43714 46415 XXX
VM 19813 206+2 X
F1 (s7p7) 54519 57919 XX
F2 & F3(p7p7) 210+2 218+3 X
F & F
(S7s7 and s7p7) 51118 546+6 XXX





(- = P,>0.05j X = P, 0.05-0.01; XX = P, 0.01-0.001; XXX = P<0.001).
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APPENDIX A HISTOLOGICAL EXAMINATION OF THE BRAINS OF ME7 INJECTED
A2G MICE AT THE TIME OF ONSET OF CHANGES IN THEIR DRINKING
AND FEEDING BEHAVIOUR (See SECTION 6)
The time at which drinking and feeding changes start to
ocour is about the same as the stage at which brain lesions are
appearing, and so the pattern of onset of the vacuolar lesions has
been examined in detail in one host/agent combination. On the
assumption that this pattern could reflect the distribution of the
fundamental lesion due to scrapie, it was thought possible that some
correlation might be found between it and the changes in drinking
and feeding behaviour whioh are characteristic of this particular
agent/host strain combination (SECTION 6, Ex. 6.8). The most
obvious expectation was that the lesions would occur in the lateral
(LH) and ventromedial hypothalamus (VMH) whioh contain the oentres for
the direot control of drinking and feeding in mammals.
Material and Methods. A2G mice were given standard i.e. injections
of ME7 agent and then killed in groups of three, 60, 70, 80, 90 and
100 days later. Standard cross-sections were prepared as usual
(SECTION 2) and in addition serial seotions of 2 of the 3 brains in
each group. These haematoxylin and eosin stained preparations were
examined for vacuolar lesions and their distribution marked on
diagrams.
Results: There were no vacuolar lesions 60 days after injection,
but from 70 days onwards they appeared and increased in severity.
The total lesion scores (SECTION 2) were as follows:
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60 day3 0.0 t 0.0
70 " 2.3 ± 0.7
80 " 6.7 ± 0.7
90 H 13.0 ± 3.0
100 " 19.0 ± 0.0
The normal total lesion score for this particular combination
in terminal cases (175 days) is 26.2 ± 0.6.
The earliest vacuolar lesions were present in the 70 day
group in the dorsal part of the hypothalamus, the hippocampus and
the caudate nuclei. They were very small and widely dispersed.
By 80 days it was apparent that the hypothalamic vaouolation was
centred on the regions immediately dorsal to the ventriole, in the
nucleus dorso-medialis, and more laterally in the perifomioular
regions and the zona incerta. Hippooampal, caudate and septal lesions
appeared or became more dense. These distributions were found at
90 days also, but with more intensity. By day 100, slight
vaouolation was also apparent in the amygdala and the central part of
the medulla oblongata; no vacuoles were found in the cerebellum.
At this time the hippocampal and hypothalamic lesions were very
conspicuous but those of the septum and caudate were still small and
scattered.
Disoussion. The most significant observation in these data is that
although the drinking and feeding changes are well-advanced by 100
days after i.e. injeotion in this particular agent/host strain
combination there was no sign of either LH or VMM vacuolation. This
\
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could mean either than these centres are not primarily involved in
the behavioural change, or that the vacuolar lesions do not
accurately represent the distribution of a more fundamental biological
lesion that is involved. It remains possible that either or both
these hypothalamic centres are malfunctioning but without yet having
proceeded into vaouolation as they do later in the incubation period.
However, of the regions where early vacuolatlon does ocour,
three of them (hippocampus, amygdala and septum) have been implicated
in * neural circuit' theories of control i.o. they have a modulatory
function with respect to the hypothalamic centres (Singer &
Montgomery, 1970). Furthermore the perifornicular region in the rat
is sensitive to both alpha- and beta-adrenergic stimulation resulting
in changed feeding responses (Leibowitz, 1970).
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APPENDIX 5 PRELIMINARY INVESTI&ATION OF THE DISTRIBUTION OF AGENT IN
SPLEEN CELLS THREE T,7BEKS AFTER AN I.C. INJECTION OF
79A IN VL MICE
The possibility that very specific cell populations in the
lymphoreticular system could be required for scrapie pathogenesis
(see SECTIONS 3 and A) prompted the following preliminary attempt to
detect a difference in scrapie titre between the glass-adhering and
the non-adhering cells from the spleens of VL mice, three weeks after
an i.e. injection of 79A agent.
Material and Methods. Three weeks after an i.e. injection of standard
79A supernate, the spleens were removed aseptically from two VL females.
By this time (assuming a similar time course to that of the ME7 agent
in C57 mice; see Dickinson & Fraser, 19&9) there should have been
a considerable amount of replication of the agent over and above the
initial accumulation of inoculum. Small pieces of the two spleens
were immediately frozen at -20°C for subsequent estimation of titre.
The rest of the two spleens was gently teased apart in cold Hank's
balanced salt solution (HBSS) and then pressed through sterile wire
gauze to separate the cells. The capsule was disoarded.
Separation of maorophage-enriched and lymphocyte-enriched
populations of oells was achieved by a simple sequential glass-adherence
technique. For this the oells were sown (about 10^ cells/ml.) in
15 mis. HBSS in flat-sided culture bottles and incubated at 37°C for
one hour initially. Then the supernatant, containing a lymphocyte-
enriched population was deoanted into a fresh culture bottle. This
process was repeated three more times: after a further one-hour and
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two half-hour perioda. Meanwhile the glass-adhering, i.e. macrophage
enriched populations, were detached from the bottles with a rubber
polioeman and stored cold to discourage further adherence.
Suspensions of both cell types were lightly centrifuged at 200g for
10 minutes and then resuspended in 1 ml. of isotonic saline.
After counting, the dilutions were adjusted to give suspensions of
25 x 106 cells/ml. These were frozen-thawed several times to kill
and disintegrate the cells which were then thoroughly homogenised
with a teflon-in-glass homogeniser. Centrifugation at 500 g for
10 mins. removed the larger pieces of cell debris.
A standard inoculum was prepared from the whole spleen
fragments whioh had been removed and frozen earlier. Inocula were
also prepared from both the macrophage-enriched and lymphocyte-enriched
c
supernates (containing 5 x 10 cells/0.02 ml. dose) and further 10 and
100 times dilutions of these (containing agent from 5 x 10^" and
5 x 103 oells per do3e respectively).
Groups of 6 or 7 VL mice were injected i.e. with 0.02 ml. of
either the standard spleen supernate (controls) or one of the three
dilutions of either the raaorophage-rioh or lymphocyte-rich supernates,
or of an equal mixture of these supernates. Incubation periods and
lesion profiles were obtained as described in SECTION 2.
Results The incubation periods are shown in Table A5.1. The
incubation period for the whole spleen supernate i.e. was 160 ± 4 days.




'type of Incubation periods
cell-donor
5 x 10^ cells 5 x 1cA cells 5 x 10^ cells
•macrophages* 175 i 3 201 ± 7 207 ± 6*




Diaoussion These results show a much higher titre than was expeoted
but give a strong Indication that the infectious unit/cell ratio was
much the same in both populations.
On the basis of three titrations performed in these
laboratories using MB7 brain in C57, RIII and VL mice it is possible
5
to estimate that the initial supernates from 5 x 10 cells contained
10*-* or about 3000 infectious units. This gives a oell/infectious
unit ratio in the order of 200/1 in both the maorophage-enriched and
lymphocyte-enriched materials. There is no way of knowing if this
represents a high infection of a few cells or a low infection of many.
Had there been a clear bias in favour of either of the populations
these results could have supported some tentative conclusions. As
they are, however, they are susceptible of several kinds of inter¬
pretation including the following!
- equal numbers of living infected oells in the macrophage
population and dead infected cells in the •lymphocyte1 population;
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- two (or more) kinds of infeoted cells nearly equally distributed
amongst glass-adhering populations and non-adhering populations;
- large numbers of leuoocytes of several "types bearing agent on
their surfaces. This could be an accumulation of the original
supernate with or without the addition of replicated agent, or even
an artifactual accumulation of agent shed by disruption of a
sub-population of very fragile cells in which the agent had been
replicating.
Sinoe this experiment was performed, a more elaborate
attempt at identifying scrapie-infected sub-populations of spleen
cells has been published by Lavelle et. al. (1972). Their results
are not comparable with those described here sinoe they examined the
spleens of terminal animals. However, it is now clear that the
results from this type of experiment aire bound to remain ambiguous
until much more is known about the dynamics of agent-leuoooyte
interactions. These are being investigated in these laboratories
using in vitro systems
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